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Amp     Ampicillin 
Ady2    Acetate transporter in Saccharomyces cerevisiae 
AUC    Area under the curve 
BLAST     Basic local alignment search tool 
Bq    Becquerel  
cDNA    complementary deoxyribonucleic acid 
Ci    Curie 
FNT    Formate nitrite transporter 
DAPI    4',6-diamidino-2-phenylindole 
DEPC    Diethylpyrocarbonate 
dNTP     Deoxynucleoside triphosphate 
DMSO    Dimethylsulfoxide 
DNA    Deoxyribonucleic acid 
E. coli    Escherichia coli 
EPM    Erythrocyte plasma membrane 
Fps1     S. cerevisiae glycerol facilitator 
G418    Geneticin 
GFP    Green fluorescent protein 
g    Gravity 
HA-tag    Human influenza hemagglutinin-tag 
HEPES     2-(4-(2-hydroxyethyl)-piperazin-1-yl)-ethanesulfonic acid 
HRP     Horseradish peroxidase 
IC50     Inhibitory concentration for a half-maximal effect 
Jen1    Lactate transporter in Saccharomyces cerevisiae 
LB medium    Luria-Bertani medium 
LDH    Lactate-dehydrogenase 
MCT    Monocarboxylate transporter 
MES     2-(N-morpholino)ethanesulfonic acid 
M-TBS-T    Milk powder and Tween 20-containing TRIS buffered saline 
NAD+    Nicotinamide adenine dinucleotide (oxidized) 
NADH    Nicotinamide adenine dinucleotide (reduced) 
NTC    Nourseothricin 
OD600     Optical density at 600 nm 
PAGE     Polyacrylamide gel electrophoresis 
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Summary 
 
A distinctive character of the mature intraerythrocytic form of the malaria parasite, 
Plasmodium falciparum, is a high glycolytic flow rate to fulfill its energetic requirements. This 
action produces two mole of lactic acid per mole of glucose as the anaerobic end product 
resulting in large quantities that need to be removed from the parasite cytosol. On its way out 
into the bloodstream lactate has to cross three different phospholipid bilayers, the parasite 
plasma membrane, the parasitophorous vacuole membrane and the red blood cell membrane. 
Although transport characteristics have been described for lactate in P. falciparum the 
molecular identity of the underlying permease(s) is still unknown. Here the discovery of a 
gene, PfFNT, responsible for the peptide that facilitates lactate transport over the parasite 
plasma membrane is described. It is a member of the formate nitrite transporter family (FNT) 
with high sequence similarities to microbial FNTs. For characterization of the protein a 
Saccharomyces cerevisiae knock out strain was employed that has lost the ability to transport 
monocarboxylates. Using this system PfFNT lactate/proton symport was found. This was 
confirmed by a direct proportionality of L-lactate transport to the prevailing pH gradient. 
Moreover when this gradient was abolished by proton decouplers, i.e. carbonylcyanide-3-
chlorophenylhydrazone (CCCP) and 2,4-dinitrophenol (DNP), transport ceased. The PfFNT 
facilitated substrate pattern fits microbial FNTs, with acetate exhibiting the highest 
permeability followed by formate, L-lactate, D-lactate and pyruvate in decreasing order. The 
dicarboxylate malonate was excluded showing selectivity of monovalent anions over 
multivalent anions which is also a common feature shared by all FNTs discovered so far. The 
non-charged molecule glycerol, which is similar in size to lactate, was also excluded. Moreover 
facilitation features, such as transport rates and inhibition profile, match earlier findings from 
measurements performed in isolated living parasites in vitro hinting at a central position of 
PfFNT in parasite metabolism. For this the antiplasmodial compounds phloretin, furosemide, 
and cinnamate derivatives where tested revealing IC50 values around 1 mM. Inhibition 
requires a negative moiety though, since the uncharged cinnamamide had no effect. Notably 
the organomercurial p-chloromercuribenzene sulfonate (pCMBS), an inhibitor of human 
lactate transport, did not alter transport rates of PfFNT. This, taken together with the fact that 
there are no FNT homologs apparent in the human genome indicates PfFNT as a novel 
promising antimalarial drug target. Additionally PfFNT is the only transporter of the 
plasmodial glycolytic pathway for which structure information is available from crystals of 
homologous proteins predisposing it to further design of high affinity inhibitors. 
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Zusammenfassung 
 
Ein herausragendes Merkmal des intraerythrozytären Malariaerregers, Plasmodium 
falciparum, ist eine hohe glykolytische Flussrate um seinen Energiebedarf zu decken. Bei 
diesem Vorgang werden aus einem Molekül Glukose zwei Moleküle Laktat gebildet, welches 
als metabolisches Endprodukt in hohen Mengen anfällt und aus dem parasitären Zytosol 
ausgeschleust werden muss. Auf seinem Weg ins Blut muss das Laktat drei Phospholipid 
Doppelmembranen überwinden, die parasitäre Plasmamembran, die parasitäre Vakuolen 
Membran und die Membran der Erythrozyten. Obwohl diese Transportprozesse in P. 
falciparum bereits beschrieben wurden, konnte die molekulare Identität der zugrunde 
liegenden Permease(n) bis jetzt nicht geklärt werden. In dieser Arbeit wurde das Gen, PfFNT, 
identifiziert das für das Peptid codiert, welches für die Laktatleitung über die Parasiten 
Membran verantwortlich ist. Es gehört zur Familie der Formiat Nitrit Transporter (FNT) und 
besitzt ähnliche Transporteigenschaften wie mikrobielle FNTs. Zur Charakterisierung des 
Proteins wurde ein Saccharomyces cerevisiae knock-out Stamm verwendet, welcher nicht dazu 
befähigt ist Monocarboxylate zu transportieren. In diesem System wurde gezeigt, dass PfFNT 
Laktat in Symport mit Protonen leitet. Dieses wurde durch eine direkt zum vorherrschenden 
pH-Wert proportionale Transportrate belegt. Zudem konnte der Transport gestoppt werden, 
indem der pH-Gradient durch Protonenentkoppler, wie Carbonylcyanid-3-
chlorophenylhydrazon (CCCP) und 2,4-Dinitrophenol (DNP) zerstört wurde. Das durch PfFNT 
geleitete Subtratspektrum entspricht dem der bisher beschriebenen mikrobiellen FNTs. Dabei 
zeigt das Acetat Molekül die höchste Permeabilität, gefolgt von Formiat, L-Laktat, D-Laktat 
und Pyruvat in absteigender Reihenfolge. Das zweifach negativ geladene Malonat wurde nicht 
transportiert, was ebenfalls zu der Selektivität der bisher beschriebenen FNTs passt, die alle 
nur einfach geladene Anionen leiten. Das ungeladene Glycerol, welches eine ähnliche Größe 
zum Laktat Molekül aufweist, wurde ebenfalls nicht transportiert. Des Weiteren passen die 
Transporteigenschaften, wie Transportrate und Inhibitionsprofil zu denen, welche aus Daten 
gewonnen wurden, die in lebenden isolierten Parasiten in vitro gemessen wurden. Dieses 
deutet auf eine zentrale Rolle von PfFNT im parasitären Metabolismus hin. Hierfür wurden die 
antiplasmodial wirkenden Substanzen Phloretin, Furosemid und Zimtsäurederivate getestet, 
welche alle IC50 Werte um 1 mM zeigen. Inhibition erfordert zudem eine einzelne negative 
Ladung da das ungeladene Zimtsäureamid keine Wirkung auf die Transportrate hat. 
Bemerkenswert ist, dass die Organoquecksilber-Verbindung p-Chloromercuribenzensulfonat 
(pCMBS), ein bekannter Inhibitor des menschlichen Laktat Transports, den Transport durch 
PfFNT nicht verändert. Dies, zusammengenommen mit der Tatsache, dass es keine homologen 
Gene zu FNTs im menschlichen Genom gibt, deutet auf eine potentielle Rolle von PfFNT als 
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neues Wirkstoffziel zur Behandlung von Malaria hin. Zusätzlich ist PfFNT der einzige 
Transporter des plasmodialen glykolytischen Stoffwechsels für den Strukturdaten aus 
Proteinkristallisationen in hoher Auflösung verfügbar sind. Daher ist PfFNT prädispositioniert 
für ein Design von hochaffinen Inhibitoren.   
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1 Introduction 
 
The human malaria parasite Plasmodium falciparum is absolutely dependent on the 
acquisition of host glucose for fulfilling its energetic needs while it resides inside human 
erythrocytes. The main waste product out of this metabolic pathway is lactate that needs to be 
removed from the cells in order to keep them viable. Although the biochemical properties of 
this transport have been characterized, the molecular identity of the parasite encoded lactate 
transporter has remained unknown. 
 
 
1.1  Malaria 
 
The species of the genum Plasmodium are the causative agents of malaria. Their highly 
specialized life cycle is divided between an Anopheles mosquito vector and a vertebrate host, 
which, depending on the parasite species, ranges from reptiles to birds, rodents and primates. 
To date there are five species that are able to infect man, P. malariae, P. ovale, P. vivax, P. 
knowlesi and P. falciparum. The latter causes the most severe form of the disease, Malaria 
tropica. The estimated cases are worldwide about 200 million while in 2012 over 600000 
deaths occurred, with approximately half of the victims being among children under the age of 
five which live in the poorest countries of the world. [World Malaria Report 2013] 
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Figure 1.1 | Life cycle of the malaria parasite. Displayed are the different 
developmental stages of the parasite during its transition from its 
mosquito host to human. [National Institute of Allergy and Infectious 
Diseases (NIAID)] 
 
 
The parasite undergoes a complex life cycle, which includes the development of a zygote, 
meiosis and subsequent asexual replication in mosquitoes (figure 1.1). Mosquitoes of the 
genum Anopheles are the primary host, which inject the infectious form of the parasite called 
sporozoites to the secondary host being vertebrates, e.g. humans [Smith et al. Mem Inst 
Oswaldo Cruz. 2014]. Here, sporozoites begin the extraerythrocytic development by invading 
liver cells (figure 1.1). In this state the parasite not only vastly multiplies to form up to 30,000 
merozoites out of one single cell but also, in the case of P. ovale and P. vivax, is able to form 
resistant dormant bodies, called hypnozoites. They are the cause for recrudescence of clinical 
malaria even after years of convalescence [Markus Parasitol Res. 2011]. Furthermore the 
released merozoites go on to invade differentiated red blood cells. In this asexual replicating 
cycle, known as schizogony, one merozoite forms up to 32 new merozoites which in turn 
reinvade new RBC’s resulting in a burden of millions of infected erythrocytes (figure 1.2) 
[Francia et al. Nat Rev Microbiol. 2014].  
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Figure 1.2 | Replication cycle of P. falciparum inside RBCs. During invasion the 
parasite is encapsuled inside a parasitophorous vacuole. Within nuclei 
replicate mitotically, first asynchronous, later synchronous. Ultimately 
new merozoites are released from the red cell completing the circle of 
schizogony. [Francia et al. Nat Rev Microbiol. 2014] 
 
 
This infection of, and replication within the red cells is the cause of the clinical symptoms of 
malaria. These symptoms differ in their periodicity depending on which of the five species 
infected the host and ultimately result in the outcome of the disease. The most deadly form is 
caused by P. falciparum [Francia et al. Nat Rev Microbiol. 2014]. This species targets a protein 
to the erythrocyte cell surface, P. falciparum erythrocyte membrane protein 1 (PfEMP1), 
which mediates binding of infected erythrocytes to the endothelial lining of blood vessels 
[Crabb et al. Cell 1997; Miller et al. Mol Biochem Parasitol. 1993]. Most likely this process leads 
to cerebral malaria, a major cause of malaria related deaths [Wassmer et al. Ann N Y Acad Sci. 
2003]. Eventually, out of this replication cycle, merozoites develop into the sexual form, which 
are called male and female gametocytes. These circle the blood stream and can be taken up 
again by a mosquito during its blood meal completing the parasitic development cycle 
[Francia et al. Nat Rev Microbiol. 2014]. P. falciparum belongs to phylum Apicomplexa which 
are generally characterised by a polar apical complex, a morphologically distinctive structure 
consisting of specialized organelles [Waller et al. Curr. Issues Mol. Biol. 2005]. Such are the 
micronemes, rhoptries and the conoid which are all located at one pole of the respective 
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invasive form. A common feature of most apicomplexans is that they are obligatory 
intracellular pathogens, while their extracellular stages inside their respective hosts are of 
short period. Another morphologically distinctive feature shared by many apicomplexans is a 
rudimentary plastid, the apicoplast, which is thought of being the result of a secondary 
endosymbiosis event between a free-living ancestor of these parasites and a red alga [Waller 
et al. Curr. Issues Mol. Biol. 2005]. Although being non-photosynthetic, the apicoplast is 
nevertheless essential for parasite survival, reasoned by several biosynthetic pathways, which 
are located within [Fichera et al. Nature 1997; Soldati Parasitol Today. 1999; Goodman et al. 
Curr Drug Targets. 2007; Lizundia et al. Antimicrob Agents Chemother. 2009].  
 
 
1.2 Plasmodial carbon metabolism 
 
During its asexual intra-erythrocytic developmental phases P. falciparum absolutely relies on 
glucose fermentation to fulfill its energetic needs [McKee et al. J Exp Med. 1946]. In this 
situation the infected RBC’s consume glucose at rates up to two magnitudes higher than 
uninfected red blood cells [McKee et al. J Exp Med. 1946]. By this, lactate is generated at the 
amount of 18 mmol l-1 min-1 that needs to be removed in order to keep the cells viable 
[Ginsburg Trends Parasitol. 2002]. On its way out of the cell, lactate must cross 3 phospholipid 
bilayers, the parasite cell membrane, the parasitophorous membrane and the host cell 
membrane. How and by which permeases this is accomplished is still elusive (figure 1.3). 
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Figure 1.3 | Lactate’s way out of the parasite. Lactate has to cross 3 different 
membranes on its way to the blood serum. Since it is charged at 
physiological pH and therefore membrane impermeable, permeases 
need to be involved. Crossing of the parasite plasma membrane (PPM) 
is thought of being accomplished by an unknown lactate/proton 
symporter. The parasitophorous vacuole membrane (PVM) is either 
fenestrated or equipped with high-capacity, low-selectivity channels. 
Either way it is freely permeable to low molecular-weight solutes 
[Desai et al. Nature 1993]. Finally, the erythrocyte plasma membrane 
(EPM) is overcome via the human MCT1 and the new permeation 
pathways (NPP) [Ginsburg et al. Mol. Biochem. Parasitol. 1983]. 
 
 
If lactate is not exported the result would be an intracellular drop in pH due to high amounts 
of protons generated by ATP depletion together with huge osmotic stress caused by doubling 
of the molar mass inside the parasite (net equation: 1 mol glucose -> 2 mol lactate, figure 1.4).  
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Figure 1.4 | Glycolytic pathway in Plasmodium. Protons are not generated during 
homolactic glucose fermentation since this process is none acidifying as 
can be seen in the net equation. When energy is freed from ATP 
hydrolysis by ATPases protons are produced in a 1:1 stoichiometry. 
Throughout glycolysis ATP is generated from oxidizing glucose to 
pyruvate. In order to restore consumed redox equivalents pyruvate is 
further reduced to lactate by fermentation. Major metabolic end-
products are displayed in red rectangles. 
 
Intriguingly Plasmodium and its host cell share the same carbohydrate metabolism, 
principally the Embden–Meyerhof–Parnas pathway of glycolysis. For the red blood cell this is 
clear due to absent mitochondria and a strongly reduced set of metabolic enzymes [Roigas et 
al. Folia Haematol 1965; Worthington et al. Eur J Biochem. 1976; Otto et al. Acta Biol Med Ger. 
1977; Morelli et al. Proc Natl Acad Sci U S A, 1978]. For the parasite the situation is a little bit 
different since plasmodia are known to have a single mitochondrion and encode for all 
necessary glycolytic enzymes [Rudzinska Int Rev Cytol. 1969; Aikawa Am J Trop Med Hyg. 
1966; van Dooren et al. FEMS Microbiol Rev. 2006; Torrentino-Madamet Curr Mol Med. 2010]. 
Nevertheless only a very small fraction of the consumed glucose is completely oxidized to CO2 
which is in line with the fact that in vitro cultures of P. falciparum require microaerophilic 
culture conditions for optimal growth while they are inhibited by atmospheric O2 
concentrations [Krungkrai et al. Southeast Asian J Trop Med Public Health. 1999; Scheibel et al. 
Exp Parasitol 1979]. During glycolysis energy is generated in the form of ATP. For this glucose 
is oxidized to pyruvate. This action consumes 2 moles of reduction equivalents, being NAD+. In 
order to keep glycolysis running and when O2 as the terminal electron acceptor is absent 
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pyruvate is further reduced to lactate. By this, lactate fermentation restores NAD+ as redox 
equivalent. The abundance and tightly regulated glucose concentration in the host blood 
serum together with the red cells reduced metabolism are thought of having led to this quite 
inefficient (e.g. oxidative phosphorylation produces up to 38 mol ATP out of 1 mol glucose vs. 
2 mol ATP for 1 mol glucose via glycolysis) but tightly host-cell-adopted metabolism of the 
parasites. But there is another argument for fermentation over oxidative respiration in 
Plasmodium. To gain amino acids the parasite consumes the host cell’s hemoglobin in large 
amounts. This is of fundamental importance since P. falciparum has entirely lost the ability of 
de novo amino acid synthesis [Liu et al. Proc Natl Acad Sci U S A 2006]. During hemoglobin 
degradation iron atoms of the heme groups are released which are known to produce 
oxidative stress, e.g. in the form of oxygen radicals [Kumar et al. Toxicol Lett. 2005]. Anaerobic 
conditions may prevent cell damage by this mechanism which indeed results in the need for 
an alternative way to produce energy in the absence of oxygen as ultimate electron acceptor – 
fermentation. It has been known for years that Plasmodium gets rid of the waste product 
lactate and at the same time deals with its proton burden through one combined mechanism, 
a lactate/proton symporter that acts in a 1:1 stoichiometry [Kanaani et al. Cell. Physiol. 1991; 
Cranmer et al. J. Biol. Chem. 1995; Elliott et al. Biochem. J. 2001]. Till now the molecular 
identity of this permease has escaped discovery. 
Comprehensively the following facts are of major interest in the malaria causing 
microbe P. falciparum: 
  Glucose is the prime energy source 
  Lactate is the major metabolic end product derived by fermentation 
  Protons are plentifully generated by ATP depletion  
  Lactate and protons need to be removed from the cell 
 
 
1.3 Lactate transport in the host: MCTs 
 
Monocarboxylates such as lactate, pyruvate and ketone bodies play key roles in the human 
energy metabolism and must be transported across cell membranes [Poole et al. Am. J. Physiol. 
1993]. For this objective a family of proton-linked monocarboxylate transporters (MCTs) has 
evolved with specialized transport properties and distinct tissue distribution. So far four 
members were discovered in the human genome and have been studied intensively 
[Halestrap Mol Aspects Med. 2013]. Common to all family members are predicted 12 
transmembrane helices (TMs) with C- and N-termini facing intracellular and a large cytosolic 
loop between TMs 6 and 7. Topology has been confirmed for MCT1 (figure 1.5) by labeling 
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studies and proteolytic digestion and a three-dimensional structure has been modelled that 
suggests a reasonable molecular transport mechanism [Manoharan et al. Mol. Membr. Biol. 
2006; Wilson et al. J. Biol. Chem. 2009]. For correct trafficking to the plasma membrane and 
also activity MCTs1-4 require association with an accessory peptide, basigin or embigin. 
These are glycoproteins that share the features of a single TM and 2 to 3 extracellular 
immunoglobulin domains.  
 
 
 
 
Figure 1.5 | Proposed structure of MCT1 in association with embigin. For 
correct expression and functionality MCTs need to be associated with 
a chaperone peptide, embigin or basigin. DIDS (grey molecule) is an 
inhibitor of monocarboxylate transport via MCTs. It’s binding to MCT1 
and embigin occurs through lysine residues in both proteins (marked 
with arrows) [Halestap IUBMB Life 2011]. 
 
 
Intriguingly it has been recently discovered that basigin is an essential receptor for 
erythrocyte invasion by P. falciparum [Crosnier et al. Nature 2011]. Further MCTs belong to 
the SLC16 family, whose members are involved in a wide range of metabolic pathways 
including energy metabolism of the brain, skeletal muscle, heart, gluconeogenesis, T-
lymphocyte activation, bowel metabolism, spermatogenesis and drug transport [Halestrap 
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Mol Aspects Med. 2013; Kobayashi et al. Int J Pharm. 2006]. For example MCTs take a central 
position in the Cori cycle. In this MCT4 acts as a lactate exporter, e.g. in type II skeletal fiber 
cells, while MCT1, that is highly expressed in heart and liver, acts as a lactate exporter. These 
properties arise from differences in substrate affinities between the two peptides. In tissue 
that is highly glycolytic but at the same time under anaerobic conditions, e.g. white skeletal 
muscles under high tension, lactate is fermented in order to restore reduction equivalents in 
the form of NAD+ consumed by glycolysis and thereby keep ATP generation running. This 
lactate is shuttled to tissue that has the appropriate enzymatic setting and sufficient supply 
with oxygen. Here, it can be either further oxidized to CO2 leading to a complete energy yield 
out of this substrate or used to rebuild glucose again (figure 1.6) [Cori Physiol. Rev 1931; 
Brooks J Physiol. 2009].  
 
 
 
Figure 1.6 | The lactate shuttle. Shown is the Cori cycle. Glucose is metabolized in 
glycolytic tissue, e.g. white fiber muscle cells to lactate. This is exported 
via MCT4 to the blood stream and imported by MCT1 in the respective 
organs for further metabolism. There, lactate can be a) used in 
gluconeogenesis to build up new glucose or b) oxidized in mitochondria 
to CO2 to get maximum energy yield. 
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Certain interest has aroused on these permeases some years ago since MCT play a key role in 
cancer metabolism and are therefore promising drug targets in cancer chemotherapy 
[Dimmer et al. Biochem J. 2000; Manning Fox et al. J Physiol. 2000].  
The prevailing hypothesis is that lactate is facilitated via MCT homologues in P. 
falciparum [Elliott et al. Biochem. J. 2001; Cranmer et al. J. Biol. Chem. 1995]. Due to a certain 
degree of sequence similarity there are two putative plasmodial MCT genes annotated 
(PFB0465c and PFI1295c; PlasmoDB.org). Moreover experiments on permeabilized infected 
RBCs revealed lactate transport characteristics and an inhibitor pattern both comparable to 
human lactate transporters, i.e. MCTs [Kanaani et al. Cell. Physiol. 1991; Cranmer et al. J. Biol. 
Chem. 1995; Elliott et al. Biochem. J. 2001]. Noteworthy to say that the only known lactate 
transporter in the RBC membrane, MCT1, is most likely not capable of coping with the vastly 
elevated lactate levels inside the infected erythrocyte cytosol [Kanaani et al. Cell. Physiol. 
1991]. Also P. falciparum produces 6-7% of its total lactate in the form of the D-enantiomer 
which is about three times slower transported by the stereoselective MCT1 compared to the 
L-enantiomer [Vander Jagt et al. Mol. Biochem. Parasitol. 1990; Broer et al. Biochem. J. 1998]. 
These facts suggest that if lactate is shuttled over the erythrocyte membrane via plasmodial 
MCT homologues at least their substrate affinities have to be different to those of human 
MCTs. 
 
 
1.4 Lactate transport in lower organisms: Formate-nitrite 
transporters  
 
Recently a new class of lactate permeases has been discovered, the formate nitrite transporter 
family (FNT), which mediate monocarboxylate transport in prokaryotes and lower 
eukaryotes. This peptide family was originally found in bacteria and knowledge on transport 
characteristics spread quickly accompanied by obtainment of numerous high resolution 
protein crystal structures [Waight et al. Curr Opin Struct Biol 2013]. 
While eukaryotes, especially mammals, are homolactic fermenters, prokaryotes use a 
wide range of compounds as terminal electron acceptors under anaerobic conditions, 
including carbon dioxide, oxidized sulfur and nitrogen substances [Clegg et al. Mol Microbiol 
2002; Kabil et al. J Biol Chem 2010]. These respiration products are tightly regulated by 
numerous enzymes, ion channels and transporters due to the fact that they have a detrimental 
potential when present at higher concentrations [Stephenson et al. Biochem J 1932]. 
Nevertheless cells can benefit by the redox potential of these anions. Under anaerobic 
conditions mixed acid fermentation results in temporary metabolic end products being mainly 
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formate and acetate. Similar to this nitrite and hydrosulfide are produced [Stokes J Bacteriol 
1949; Sawers Microbiology 2006]. To deal with transport of these compounds across lipid 
bilayers the family of formate nitrite transport channels (FNTs) has emerged [Suppmann et al. 
Mol Microbiol 1994; Sawers Antonie Van Leeuwenhoek 1994]. This family can further be 
divided into three subfamilys, the formate channels (FocA) [Suppmann et al. Mol Microbiol 
1994], the nitrite channels (NirC) [Jia et al. Biochem J 2009] and the hydrosulfide channels 
(HSC) [Czyzewski et al. Nature 2012]. The overall protein structure of this family is well 
known since plentiful data on 3-d high resolution crystals has been collected. These peptides 
form homomeric pentamers in the phospholipid membrane as functional units (figure 1.7 1) ). 
These, although sharing absolutely no sequence similarities, have a similar tertiary structure 
as aquaporins, a phenomenon referred to as molecular mimicry (figure 1.7 2) and 3) ) [Wang 
et al. Nature 2009]. 
 
 
 
Figure 1.7 | FNT structure and comparison to aquaporins. Shown is 1) the 
pentameric structure of FocA from Vibrio cholera [Waight et al. Nat 
Struct Mol Biol 2010] and its superposition with bovine AQP1 [Sui et 
al. Nature 2001], 2) top view from the extracellular side, 3) side view 
from within the membrane. FocA = orange, AQP1 = purple [Waight et 
al. Curr Opin Struct Biol 2013]. 
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The protomers are each composed of six tilted transmembrane -helices and two half helices 
forming a right-handed bundle that surrounds a 15-Å long narrow pore, which is believed to 
be the permeation pathway for anions (figure 1.7 2) ). The overall structures of the FNT 
subfamilies show only minor differences, resulting in a high degree of similarity between 
them. This is reflected in the conduction profile of FNTs: they transport monovalent anions, 
ranging from small inorganic compounds such as nitrite to larger organic molecules like 
acetate [Czyzewski et al. Nature 2012; Lü et al. Proc Natl Acad Sci U S A 2012]. Albeit having a 
polyspecific anion substrate pattern FNTs are non-conductive for cations and multivalent 
anions [Wang et al. Nature 2009; Lü et al. Science 2011; Whaigt et al. Nat. Struct. Mol. Biol 
2010; Lü et al. Proc. Natl. Acad. Sci. USA 2012; Czyzewski et al. Nature 2012].  
Notably the FNT family is widely distributed among enteric bacteria such as Escherichia 
and Salmonella species [Saier et al. Biochim. Biophys. Acta 1999]. With the fact that many of 
these cause severe human illnesses, FNT proteins may function as valuable drug targets. In 
fact they might hold the potential to lead to the discovery of a novel class of antibiotics.  
 
 
1.5 Aim of this work 
 
The primary objective of this thesis is to identify and test candidate proteins responsible for 
lactate transport over the parasite membrane. If a hit is found its transport properties will be 
characterized. Also a set of known inhibitors for P. falciparum lactate transport will be tested. 
Candidate testing and characterization will be based on a mutant yeast strain, with 
phenotypic as well as radioactive tests.  
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2 Materials 
 
 
2.1 Chemicals and enzymes 
 
AppliChem, Darmstadt 
MES, Tween 20, SDS, Streptomycinsulfate, LB-Agar-Powder, 
Glycine, LB-Medium-Powder, Phosphoenolpyruvate, Magnesiumacetate 
 
Becton Dickinson and Company, Heidelberg 
Bacto Proteose Peptone No. 3, Bacto Agar, Bacto Peptone, Bacto Tryptone, Bacto 
Yeast Extract 
 
Bio-Rad, Munich 
Bio-Rad Protein Assay-Reagent 
 
Fermentas, St.Leon-Rot 
Restriction enzymes, dNTPs, T4-DNA Ligase, RiboLock RNase Inhibitor 
 
Genaxxon BioScience, Ulm 
Agarose LE, Ampicillin, TEMED 
 
GE Healthcare, Freiburg 
PD MidiTrap G25, ECL plus Western-Blotting Detection System, Hybond-P Western 
Blot-Membranes, Q-Sepharose Fast Flow, Whatman Nuclepore Track-Etch 
Membranes, Whatman Chromatography Paper 3MM 
 
J.T.Baker, Munich 
Methanol, Ethanol, Isopropanol, Acetic acid 
 
Merck, Darmstadt 
Glycine, Potassiumchloride, di-Sodiumhydrogenphosphate-dihydrate, Sodiumformate, 
Saccharose, Dimethyl sulfoxide, G 418 Sulfate 
 
MP Biomedicals, Illkirch, France 
Ethidiumbromide 
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Peqlab, Erlangen 
peqGOLD Prestained Protein Marker III 
 
Promega, Mannheim 
Wizard Plus SV-Minipreps DNA Purification System 
 
R-biopharm, Darmstadt 
Enzytec(TM) L-Milchsäure Test 
 
Roche Diagnostics, Mannheim 
cOmplete EDTA-free Protease inhibitor cocktail tablets 
 
Roth, Karlsruhe 
Ammoniumperoxodisulfate, Ammoniumsulfate, Boric acid, Glycerol 86 %, Urea, 
HEPES, di-Potassiumhydrogenphosphate, Potassiumchloride, Lithiumchloride, MOPS, MES, 
Sodiumdihydrogenphosphate-Monohydrate, Sodiumhydrogencarbonate, TRIS, Tween 20, 
Triton X 100, Sodiumhydroxide, Sodiumchloride, Kanamycetinsulfate, L-Arginine, L-Leucine, 
L-Proline, LB-Agar (Lennox), Milkpowder, Bromphenolblue, D(+)-Glucosemonohydrate, LB-
Medium (Lennox), D(+)-Saccharose, Rotiphorese Blue R, Calciumchloride, Albumin Fraction V 
(BSA), Trichloroacetic acid, Ethylenediaminetetraacetic acid, Potassiumacetate, Sodiumazide, 
Triton X-100, Saccharose, Dithiothreitol, Tris, Boric acid, Pen/Strep-PreMix, 2-
Mercaptoethanol 
 
Sigma-Aldrich, Munich 
Poly(ethylene glycol) 8000, 2-(N-morpholino)ethanesulfonic acid, Glass beads, 
Sodiumformate, Sodiumgluconate, Sodiumnitrate, Urea, L-Asparagine Monohydrate, L-
Arginine Monohydrochloride, L-Aspartic acid Sodiumsalt Monohydrate, L-Cysteine, L-
Glutamic acid Sodiumsalt 
Monohydrate, L-Alanine, L-Glutamine, L-Histidine Monohydrochloride Monohydrate, L-
Isoleucine, L-Methionine, L-Lysine Monohydrochloride, L-Phenylalanine, L-Tryptophan, L-
Tyrosine, L-Threonine, L-Valine, Hepes, Imidazole, Potassium-D-gluconate, L-Serine, L-
Proline, Acetylphosphate, ATP, CTP, GTP, UTP 
 
Stratagene, La Jolla, USA 
PfuTurbo DNA Polymerase 
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Südlaborbedarf, Gauting 
High Yield PCR Clean-Up & Gel-Extraction Kit 
 
Thermo Fischer Scientific, Waltham, USA 
First Strand cDNA Synthesis kit 
 
Zinsser Analytic, Frankfurt 
Scintillation cocktail Quicksafe A 
 
 
2.2 Equipment 
 
Adolf Wolf SANOclav, Bad Überkingen-Hausen  
Autoclave for sterilization 
 
Agilent Technologies, Waldbronn 
UV/Vis-Spectrometer Varian Cary 50 UV-Vis 
 
Beckman Coulter, Krefeld 
Optima XL-80K Ultracentrifuge, SW 60 Ti Rotor Swinging Bucket, 50.2 Ti, Centrifuge 
Tubes Microfuge Tube Polyallomer 1.5ml 
 
Bio-Rad, Munich 
Power Pac 2000, Transblot SD semidry transfer cell 
 
Clemens, Waldbüttelbronn 
PCR-machine Primus advanced HT2X and HT Manager Software 
 
Eppendorf, Hamburg 
Photometer BioPhotometer, Centrifuge 5415R 
 
Grant-bio, Hillsborough, USA 
Rotator Mixer PTR-30 
 
Heraeus Instruments, Osterode  
Centrifuge Multifuge 1S-R, Microcentrifuge Biofuge pico 
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Infors, Bottmingen, Swizzerland 
Incubation board Infors 
 
Kern & Sohn, Balingen  
Special accuracy weighing machine ABS 120-4 
 
New Brunswick Scientific, Wesseling-Berzdorf 
Deep-freeze cabinet U535 innova 
 
Osram, Augsburg 
Halogen lamp “64607 EFM”, 8 V 50 W, for “Bioscreen” (ordered via iLF bioserve, Germany, 
from Oy Growth Curves, Finland) 
 
Oy Growth Curves, Helsinki, Finland 
Combined incubation shaker and turbidometer “Bioscreen C microbiology reader” 
100-well plates “Honeycomb 2” 
Software “EZExperiment” 
 
Peqlab, Erlangen 
SDS-gel-casting stand and –running chamber 
 
Raytest, Straubenhardt 
Gel-documentation-dystem IDA 
 
Roche Diagnostics, Mannheim 
Picture-documentation-system Lumi Imager F1 
 
Savant Instruments, Farmingoale, USA  
DNA SpeedVac R110 Vakuumcentrifuge 
 
Schott Instruments, Mainz 
pH-Meter Lab 850 
 
Scientific-Industries, Bohemia, USA  
Vortex Genie 2  
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SG Wasseraufbereitung und Regenerierstation, Barsbüttel  
Ultrapure water system 
 
WTB Binder Labortechnik, Tuttlingen  
Hot-air steriliser, Incubator 
 
PerkinElmer Inc., Waltham, USA 
Packard TriCarb liquid scintillation counter 
 
 
2.3 Plasmids used 
 
Plasmid structures were generated using the PlasMapper software (version 2.0). 
 
 
 
Figure 2.1 | pBluesript II SK(-). Cloning vector used for site directed mutagenesis  
in E. coli. 
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Figure 2.2 | pHA426MET25r. Yeast high copy shuttle vector. Used in E. coli and  
S. cerevisiae 
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Figure 2.3 | pRS413(met25). Yeast high copy shuttle vector. Used in E. coli and  
S. cerevisiae. Derived from pBluesript II SK(-). 
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Figure 2.4 | pDRTXa. Yeast high copy shuttle vector. Used in E. coli and S. cerevisiae. 
Has a N-terminal HA- and a C-terminal 10x His-tag, with the latter being 
cleavable due to an upstream factor Xa recognition site. 
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Figure 2.5 | pARL1-GFP. Expression vector in P. falciparum with a C-terminal  
GFP-tag. 
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2.4 Primer and oligonucleotides used 
 
 
Primer name Sequence 
T7 sequencing primer TAA TAC GAC TCA CTA TAG GG 
T3 sequencing primer GTG TAA GTT GGT ATT ATG TAG 
PMA5‘ sequencing primer CTCTCTTTTATACACACATTC 
ADH3‘ sequencing primer CATAAATCATAAGAAATTCGC 
rMCT1-F(Spe) gagagaACTAGTATGCCACCTGCGATTGGCGGGCCAGTG 
rMCT1-rv(Sal) gagagaGTCGACGACTGGGCTCTCCTCCTCCGCGGGGTC 
rMCT1 ’985 rv sequencing 
primer 
GGCACACTCCATTCGCAACAACAGA 
rMCT1 ’599 f sequencing 
primer 
CTCAGCAAGGCAAGGTGGAAAAACTCAAG 
hMCT4-F(Bam) gagagaGGATCCATGGGAGGGGCCGTGGTGGACGAG 
hMCT4-rv(Sal) gagagaGTCGACGACACTTGTTTCCGGGGTGTGAAC 
hMCT4 ’1072 Rv 
sequencing primer 
GCCACCGCCTCCATCAGCAGCACCAG 
hMCT4 ’549 F sequencing 
primer 
GGGCGGCCTGCTGCTCAACTGCTGCGTGTG 
SceJEN1 Rv 3’ (SalI) TCT gtc gac TTA AAC GGT CTC AAT ATG CTC CTC 
SceJEN1 F 5’ (BamHI) AGA gga tcc ATG TCG TCG TCA ATT ACA GAT GAG 
ScJen1 iF sequencing 
primer 
TGC GTT TCA GTA TCA GTC GC 
ScJen1 iRv sequencing 
primer 
TCA TAC CCC CAC AAA TAG CAC 
Pf70 F 5’ (SalI) 
TACGACGTTCCTGACTACGCGGACactagtATGAATATAATACCTTCA
ACAGCTGTG 
Pf70 Rv 3’ (XhoI) 
CCTTACTTATGTGTATCTTGACAAActcgagATCGAGGGAAGGGTCG
AGCAC 
Pf70 ’563 iF sequencing 
primer 
AAGATGTTTTGAATAGAGT 
Pf70 ’646 iRv sequencing 
primer 
TTCTGGATCATTGTCCATTTTAACTTCCATGGTTGC 
Pf75 F 5’ (SpeI) TACGACGTTCCTGACTACGCGGACactagtATGAAAAAAGAGAATAC
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TTCCCTGTTATC 
Pf 75 Rv 3’ (XhoI) 
CAGCATCATGTTAGCACTAGCATTTctcgagATCGAGGGAAGGGTCG
AGCAC 
PfFNT F 5’ (BamHI) GAGAGAggatccATGCCACCAAATAATTCCAAATATGTTTTAGATC 
PfFNT Rv 3’ (XhoI) CTCAAATGAAAAGTTTATCTATAGAATTACGAAATctcgagTCTCTC 
 
 
2.5 Organisms 
 
 
2.5.1 E. coli strains 
 
Stratagene, Waldbronn 
Escherichia coli XL1-blue MRF’ 
 
Escherichia coli DH5 F− '80lacZ15M(lacZYA-argF)U169 recA1 endA1 phoA supE44 
hsdR17(rk−, mK+)− thi-1 gyrA96 relA1 
 
 
2.5.2 S. cerevisiae strains 
 
Saccharomyces cerevisiae W303-1A Δjen1 Δady2 (MATa, can1-100, ade2-1oc, his3-11-15, 
leu2-3,-112, trp1-1-1, ura3-1, jen1::kanMX4, ady2::hphMX4) kindly provided by M. Casal 
 
Euroscarf, Frankfurt  
Saccharomyces cerevisiae BY4742 (Brachmann et al., 1998)  
Saccharomyces cerevisiae BY4742Δfps1 (MATa, his3-1, leu2Δ0, lys2Δ0, ura3Δ0, fps1::kanMX) 
 
Own laboratory 
Saccharomyces cerevisiae BY4742Δjen1Δady2Δcyb2 LDH (MATa, his3-1, lys2Δ0, ura3Δ0, 
Δcyb2+LDH::kanMX, Δady2::NAT, Δjen1::LEU2) 
Saccharomyces cerevisiae BY4742Δjen1Δady2Δcyb2Δadh1 LDH (MATa, lys2Δ0, ura3Δ0, 
Δcyb2+LDH::kanMX, Δady2::NAT, Δjen1::LEU2, Δadh1::HIS3) 
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2.5.3 Plasmodium strain 
 
Plasmodium falciparum 3D7 
 
 
2.6 Antibodies 
 
Anti HA 12CA5 mouse, monoclonal, Roche 1:5000/ 1:2000 (dilution first/second antibody) 
Penta-His mouse, monoclonal, Qiagen 1:5000/ 1:5000 (dilution first/second antibody) 
HRP-Conjugated anti-mouse goat, Jackson Immuno Research 
 
 
2.7 Buffer and media 
 
AppliChem, Darmstadt 
LB medium powder (Lennox), LB agar (Lennox) 
 
Becton Dickinson, Heidelberg 
Bacto Agar, Bacto Peptone, Bacto Tryptone, Bacto Yeast Extract, Difco Yeast Nitrogen Base 
w/o Amino Acids and Ammonium (YNB) 
 
Oxoid, Basingstoke, UK 
Agar Bacteriological  
 
Roth, Karlsruhe 
LB medium powder (Lennox), LB agar (Lennox) 
 
E. coli growth media 
1000 x Ampicillin 
(ampicillin Na 10 %, -20 °C) 
 
1000 x Tetracyclin 
(tetracyclin 1.5 %, -20 °C) 
 
LB medium (Lennox) 
(tryptone 1 %, yeast extract 0.5 %, NaCl 0.5 %, or prepared from LB-medium-powder 2 %) 
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LB agar (Lennox) 
(tryptone 1 %, yeast extract 0.5 %, NaCl 0.5 %, Bacto Agar 1.5 %, or prepared from LBagar- 
powder 3.5 %) 
 
Antibiotic-containing LB media 
(ampicillin 100 μg/ml or tetracycline 15 μg/ml, added after autoclaving) 
 
S. cerevisiae growth media 
1000 x Histidine 
(L-histidine HCl·1H2O 2 %, 4 °C) 
 
200 x Leucine 
(L-leucine 2 %) 
 
1000 x Lysine 
(L-lysine HCl 2 %, 4 °C) 
 
100x Uracil 
(0.2 %) 
 
200x Adenine 
(0.5 %) 
 
500x Tryptophan 
(0.5 %, 4 °C) 
 
100x L-lactate 
(2.5 %) 
 
YPD 
(yeast extract 1 %, peptone 2 %, D-glucose 2 %) 
 
SD KHL 
(YNB 0.17 %, (NH4)2SO4 0.5 %, D-glucose·H2O 2 %, NaOH → pH 5.6, L-lysine HCl 20 mg/l, 
L-histidine HCl·1H2O 20 mg/l, L-leucine 100 mg/l) 
Amino acids were added after autoclaving. 
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SLac AHLW 
(YNB 0.17 %, (NH4)2SO4 0.5 %, L-lactate 0.25 %, pH was set either with NaOH or HCl to pH 
5.0 (buffered with succinate 0.25 mM)/ 6.0 or 6.5 (buffered with MES 20 mM)/ 7.0 or 7.5 
(buffered with TRIS 50 mM), adenine 25 mg/l, L-histidine HCl·1H2O 20 mg/l, L-leucine 100 
mg/l, L-tryptophan 10 mg/l) 
Amino acids and L-lactate were added after autoclaving. 
 
YPD and SD KHL agar 
(Oxoid Agar 2 % in the respective media) 
 
P. falciparum buffer 
Standard buffer (125 mM NaCl, 5 mM KCl, 20 mM glucose, 25 mM HEPES, 25 mM MES, 1 mM 
MgCl2, pH 6.8) 
 
L-lactate buffer (125 mM NaCl, 5 mM KCl, 1 mM MgCl2, 20 mM glucose, 25 mM HEPES, 25 mM 
MES and 5 mM L-lactate sodium salt (final concentration) pH 6.8 and 0.1 µCi/µl) 
 
Oil phase (5:4 Dibutylphthalate/Dioctylphthalate)  
 
3   Methods 
 
 
 
30 
3 Methods 
 
 
3.1 Molecular biology methods 
 
3.1.1 E. coli competent cells generation 
 
For the generation of competent E. coli cells either the DH5α-strain or the XL1-Blue-strain was 
used. When DH5α bacteria were used no addition of antibiotics to the growth medium was 
necessary contrary to XL1-Blue cells, where 15 mg/l tetracycline was added to the LB-
medium.  
5 ml of medium were inoculated with bacteria and grown overnight (with 200 rpm 
shaking) at 37 °C. Out of this pre-culture a 100-fold dilution in 100 ml was generated which 
was incubated at again 37° C with shaking until an OD600 of 0.3 - 0.6 was reached. These cells 
were harvested with centrifugation at 2000 g for 10 minutes and kept on ice. The resulting 
pellet was washed twice with a 0.1 M CaCl2 solution and resuspended in 10 ml of 0.1 M CaCl2 
containing 20 % glycerol. Accordingly cells were incubated on ice for at least four hours and 
aliquotated to 100 µl in 1.5 ml reaction tubes which were stored at   -80 °C. 
 
 
3.1.2 E. coli transformation 
 
A 100 µl aliquot of competent E. coli cells was taken out of the -80 °C freezer and incubated on 
ice for about three minutes. Less than 25 µl DNA-solution was pipetted to the cells which were 
again incubated on ice for 30 minutes. Followed by one minute heat shock at 42 °C, the E. coli 
were kept on ice for another two minutes. Subsequently 900 µl LB medium was added to the 
cells and incubated for one hour at 37 °C with shaking on a roller drum. After centrifugation of 
the E. coli at 13000 g for 15 seconds 900 µl medium was discarded and the cells resuspendend 
in the remaining 100 µl. The cell suspension was plated on agar plates containing the 
appropriate antibiotic for selection and incubated over night at 37 °C. 
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3.1.3 E. coli cultivation and generation of permanent cultures 
 
If not indicated elsewise all cultivation of E. coli was performed at 37 °C. First cells derived 
from either transformation or out of glycerol stocks were spread on agar plates and incubated 
overnight. On the next day single colonies were picked and incubated in 4 ml liquid LB 
medium for another overnight period. For longer storage of these cultures 0.5 ml cell 
suspension was mixed with 0.5 ml glycerol 85% in a 1.5 ml reaction tube and frozen at -80 °C. 
 
 
3.1.4 E. coli plasmid DNA isolation 
 
Isolation of E. coli plasmid DNA was achieved using a commercial kit Wizard® Plus SV 
Minipreps (Promega) and executed according to the manufacturers manual.  
 
 
3.1.5 Purification and determination of DNA concentration  
 
In order to purify DNA for cloning it was processed via a commercial kit the HiYield® PCR 
Clean-up/Gel Extraction Kit (SLG®) either directly, e.g. if a restriction enzyme digestion was 
done or after an agarose gel electrophoresis.  
For separation of DNA by size agarose gel electrophoresis (1 % agarose in 50 ml TAE 
buffer with 1 µl ethidiumbromide) was used. Samples were mixed with a loading buffer and 
separated by electrophoresis at 100 V for 20 minutes. The size and the concentration of the 
fragments were estimated by comparing them to a size marker consisting of PstI-digested λ-
DNA under a UV light at 366 nm (figure 3.1). 
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Figure 3.1 | Lambda DNA size marker. The DNA of the phage is digested with PstI 
[New England Biolabs]. 
 
 
3.1.6 DNA sequencing  
 
Sequencing was accomplished by using a CEQTM 8000 Genetic Analysis System of Beckman 
Coulter®. Here the DNA was separated by capillary gel electrophoresis and visualized by 
fluorescence dye labeled didesoxyribonucleoside-triphosphates (ddNTPs) during PCR 
amplification. For this 50 – 150 fmol dsDNA was used in an optimal DNA to primer ratio of 
1:40. 6 µl DNA and primer were mixed with 4 µl “GenomeLab DTCS - Quick Start Master Mix” 
and the following PCR program was run: 
 
 
Initial denaturation 96 °C  5 minutes 
Denaturation 96 °C 20 seconds  
30x Annealing 50 °C  20 seconds 
Elongation 60 °C  4 minutes 
Storage 8 °C Infinite 
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After running the PCR to each sample 5 µl stop solution was added containing 2 µl 3 M NaOAc 
pH 5.2, 2 µl 100 m M EDTA pH 8.0 and 1 µl 20 mg/ml glycogen. Further DNA purification was 
done by ethanol precipitation where each sample was transferred to a 1.5 ml reaction tube. 
Here 60 µl ice cold 95% ethanol was added and afterwards immediately centrifugated at 15 
000 g for 15 minutes. After carefully removing the supernatant the resulting pellet was 
washed twice with ice cold 70% ethanol followed by drying for 15 minutes in the SpeedVac®. 
The dry pellets were resuspended in 30 µl “Sample Loading Solution (SLS)” and analyzed in 
the sequencer.  
Results were interpreted using the DNASTAR software. 
 
 
3.1.7 DNA modification 
 
DNA cloning was done to multiply desired DNA. For this, the gene sequence and a plasmid had 
to be digested with compatible ends generated by suitable restriction enzymes. The vector 
was additionally dephosphorylated with Calf Intestine Alkaline Phosphatase (CIAP). 
Furthermore the DNA was purified by either a commercial kit or by gel purification (see 
3.1.5), ligated via the T4 DNA Ligase and transformed into E. coli for amplification (see 3.1.2). 
A control digestion was done verification. After a site directed mutagenesis the modified DNA 
was sequenced additionally. 
 
 
3.1.8 Polymerase chain reaction 
 
The PCR is a multi-purpose tool used not only for simple amplification of pieces of DNA but 
also, if slightly modified, for many other applications, e. g. site directed mutagenesis, 
generation of single strand copy DNA and sequencing. 
For standard PCR the template DNA that had to be amplified was mixed with two 
sequence specific primers (each 0.5 µM), dNTPs (each 200 µM), 5x OneTaq Standard  
Reaction Buffer (NEB) and OneTaq DNA Polymerase (NEB). The total volume was set with 
ddH2O to 50 µl. The temperature settings were adapted to the template DNA, the primers and 
the length of the generated PCR product. The standard program was as following:  
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  Denaturation 95 °C 5 min 
   Denaturation 95 °C 1 min 
 
30x 
 
 
Annealing Tm 30 s 
  Extension 68 °C 1-3 min 
   Final extension   68 °C                     10 min 
 
 
Storage 8 °C ∞ 
 
     
  The number of cycles was depended on the quality of the template DNA, mostly it was set to 
30 times. The annealing temperature Tm was depended on the composition of the primer pair 
and was calculated with the following formula: 
𝑇m= 4 ∙ (GC%) + 2 ∙ (AT%) 
With GC% and AT% being the percentaged concentrations in the primers. The extension time 
was calculated with: 
𝑡 = 0.06 ∙ 𝑏𝑎𝑠𝑒 𝑝𝑎𝑖𝑟𝑠 𝑜𝑓 𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑝𝑟𝑜𝑑𝑢𝑐𝑡 𝑙𝑒𝑛𝑔ℎ𝑡 
Note that this time was never less than 1 minute. 
 
 
3.1.9 Site directed mutagenesis 
 
This PCR variation was used to mutate specific single amino acids in gene sequences. 
For the PCR 50 ng of pBluescript plasmid DNA containing the gene coding sequence was used 
together with 30 µM of the respective forward and reverse primers which contained the 
desired sequence alterations. Furthermore dNTPs, the Pfu Turbo® DNA Polymerase AD 
Puffer and the Pfu Turbo® DNA Polymerase AD were added in a reaction tube and 
throughoutly mixed. The reaction tube was placed inside a termocycler and the following 
program was run: 
 
      Denaturation 95 °C 2 min 
   Denaturation 95 °C 1 min 
 
30x 
 
 
Annealing 55 °C  1 min 
  Extension 68 °C 15 min 
   Final extension  68 °C                      10 min 
 
 
Storage 8 °C  ∞ 
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After running the PCR program the template DNA was digested with DpnI at 37 °C for 
overnight. On the next day purification of the synthesized DNA was carried out as described in 
3.1.5. With the newly generated plasmid E. coli competent cells were transformed followed by 
sequencing to ensure a successful mutation. 
 
 
3.1.10 Colony PCR 
 
This protocol was designed to quickly screen for positive mutations in the genome of bacteria 
or yeasts. Parameters of the method were similar to the standard PCR with the exception that 
instead of purified DNA a lysate of a single clone was used. A clone was picked with a pipette 
tip and suspended in 20 µl of ddH2O. This suspension was boiled at 95 °C for 30 seconds and 
spun down 16,000 g for 2 seconds. 5 µl of the supernatant were used as template for PCR (see 
3.1.8). 
 
 
3.1.11 First strand cDNA synthesis 
 
First strand cDNA synthesis was needed to obtain coding DNA without introns from P. 
falciparum RNA. A commercial kit, “First Strand cDNA Synthesis Kit” (Thermo Scientific) was 
used. Afterwards the generated cDNA was directly used as template for amplification of the 
desired genes. 
 
3.1.12 S. cerevisiae transformation  
 
For transformation the strain was inoculated in 5 ml YPD medium and grown overnight at 29 
°C with 200 rpm shaking. The culture was diluted in 50 ml YPD medium to an OD600 of 0.2 and 
incubated at 29 °C with 200 rpm shaking till the OD600 reached about 0.6 (being normally 
about four hours). Cells were collected at 3000 g for 5 minutes and washed twice with 25 ml 
ddH2O and finally resuspended in 1 ml ddH2O. For each transformation 100 µl yeast 
suspension was pipetted into 1.5 ml reaction tubes and centrifuged again at 13000 rpm for 
another 30 seconds. The supernatant was discarded and 360 ml transformation mix (240 ml 
PEG3500 (50 %), 36 ml 1 M lithium acetate, 50 ml boiled single-stranded-carrier DNA, 34 ml 
ddH2O and 0.4 ml plasmid-DNA) were added. Immediately after adding the mix, cells were 
resuspended by rubbing the reaction tubes over a plastic rack. Thereafter the tubes were 
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incubated at 42 °C for 1 hour, centrifuged at 13000 rpm for 30 seconds and the supernatant 
was discarded. The obtained pellet was resuspended in 1 ml ddH2O. 100 µl were plated onto 
agar plates containing the appropriate nutritional composition for selection. The plates were 
incubated at 29 °C for 3 to 5 days. 
 
 
3.1.13 Yeast glycerol stock generation  
 
500 µl of an overnight culture of S. cerevisiae was thoroughly mixed with glycerol 80% and 
immediately frozen at -80 °C. 
 
 
3.1.14 Gene knock-out in S. cerevisiae 
 
Genetic modification of yeasts was necessary to sustain a strain that was unable to grow on L-
lactate as the sole carbon source without a suitable exogenous lactate-facilitator. The method 
used is a PCR-based gene deletion strategy derived from Baudin et al. (1993). 
First, mutation primer had to be designed. They had to be complement to approximately 
45 base pairs of the region up- and downstream of the desired gene sequence in the yeast 
chromosomal genome. With these primers a resistance cassette was amplified by PCR. The 
product was directly transformed into the selected yeast strain. Transformation was executed 
(see 3.3.1) with the difference that after the heat shock cells were resuspended in 1 ml YPD 
medium and incubated for another 2 to 3 hours at 29 °C with 200 rpm shaking. During this 
incubation homologous recombination occurred (figure 3.2). Afterwards cells were plated and 
incubated like previously described (see 3.1.12). 
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Figure 3.2 | Homologous recombination in yeast. A PCR product is directly used 
for exchange with a defined chromosomal sequence via homologous 
recombination in S. cerevisiae. Note that the homologous linker arms 
consist only of about 45 base pairs. ORF = open reading frame, kanMX4 
= kanamycin resistance cassette  
 
 
From the resulting plates 4 single colonies were plated again on selection agar and incubated 
for another 3 to 5 days at 29 °C. To verify the knock out a colony PCR was performed (see 
3.1.10). Positive clones for the intended gene knock were taken for permanent culture 
generation (see 3.1.13). 
 
 
3.2 Protein analytics 
 
3.2.1 Protein quantification  
 
In order to estimate the protein concentration of yeast microsomal fractions the Bradford 
assay was carried out. For this commercial available “Bio-Rad Protein Assay” reagent was 
used. A calibration curve with bovine serum albumin (BSA) as a standard is inevitable for 
estimating the protein concentration. For the measurement 0.8 to 8 µl of the sample were 
diluted in 800 µl distilled water and mixed with 200 µl of the Bio-Rad reagent. After 
incubation of 5 to 10 minutes at room temperature the sample was measured at 595 nm wave 
length with distilled water as blank.  
 
3   Methods 
 
 
 
38 
3.2.2 SDS PAGE 
 
Sodium lauryl sulfate polyacrylamide gel electrophoresis is a valuable method to separate 
proteins (mainly) by size. Thereby the anionic detergent SDS denaturizes the peptides and 
copes the ionic charges of the amino acid residues to an overall negatively charged molecule 
which is then separated through a gel matrix by its electrophoretic mobility. Since the charge 
of all peptides is negative due to the SDS treatment smaller molecules are able to move faster 
to the anode and therefore are separated from the bigger, i. e. longer protein chains. The gel 
typically consists of a resolving and a stacking unit which are composed as follows: 
      
      
 
  
Resolving gel 
Stacking 
gel 
 
 
12.5% 15%   
 
 
ddH2O 5.25 ml 4.5 ml 2.4 ml 
 
 
Resolving gel 
buffer 
3.0 ml 3.0 ml - 
 
 
Stacking gel buffer - - 1.0 ml 
 
 
Acrylamide (40%) 3.75 ml 4.5 ml 0.6 ml 
 
 
TEMED 10 µl 10 µl 6 µl 
 
 
APS (10%) 80 µl 80 µl 25 µl 
 
      
      For denaturation, membrane-proteins were incubated with 4x SDS loading buffer for 30 
minutes at 37 °C. The gel was polymerized between two glass plates in a gel caster with a 
comb on top to generate sample pockets. Once the samples are loaded onto the gel 160 V were 
applied till the samples had run through the stacking gel. At this point the voltage was 
increased to 200 V. When the samples had reached to middle of the resolving gel voltage was 
switched off. After this the gel was either stained with Coomassie-blue or transferred onto a 
PVDF membrane for Western blotting. For staining, Coomassie Brilliant Blue (“Rotiphorese 
Blue R”) was used. Here the SDS gel was incubated shakingly at room temperature for one 
hour. Destaining solution was used untill the background staining had lowered appropriately 
and bands became visible.  
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3.2.3 Western-Blotting 
 
Typically Western-Blotting was used to visualize peptides after they have been separated by 
SDS PAGE. Here proteins are transferred onto a PVDF membrane and specifically detected by 
antibodies. After gel electrophoresis the SDS gel was placed between six Whatman® papers 
which had been soaked in transfer buffer solution and a PVDF membrane which had been 
activated by incubation in methanol for five minutes at room temperature. The proteins were 
transferred at 17 V for 1 hour to the PVDF membrane. When the blotting was completed the 
membrane with the transferred proteins was blocked for 1 h in TBS-T solution with 3% milk 
powder at room temperature. Subsequent the membrane was incubated shakingly with the 
primary antibody in TBS-T containing 3% milk powder overnight at 4 °C. At the next day non 
bound antibodies were washed off with TBS-T solution shakingly for 15 minutes at room 
temperature. This was repeated three times. Afterwards the secondary antibody was added 
and incubated for one hour at room temperature with shaking. The following washing steps 
were carried out like done before. To activate the horseradish peroxidase of the secondary 
antibody it was incubated in a commercially available reaction mix (“ECL Plus Western 
Blotting Detection System”, GE Healthcare) for 5 minutes at room temperature. The resulting 
chemiluminescence was detected in an imaging and gel documentation system (Lumi-Imager 
F1TM, Roche).  
 
 
3.2.4 Isolation of the S. cerevisiae microsomal fraction  
 
In order to isolate membrane proteins in yeast the following method was applied. A colony of 
transformed yeast cells was picked from an agar plate and inoculated in 100 ml medium for 
one to two days at 29 °C with shaking till the OD600 reached about 1. After centrifugation at 
3000 g for 5 minutes cells were washed first with 50 ml water and second with 1 ml 
precooled extraction buffer. Thereafter the cells were resuspended in 0.5 ml precooled 
extraction buffer containing 15 µl protease-inhibitor-mix (25×) and kept on ice for the rest of 
the procedure in 50 ml falcon tubes. An equal volume of acid washed glass beads was added 
and vortexed for 10 times for 30 seconds with incubation on ice for also 30 seconds in 
between. Subsequent the yeast cells were collected by centrifugation at 13000 g for 5 minutes 
at 4 °C. The supernatant was kept and transferred to ultracentrifugation tubes. The remaining 
pellet was again resuspended in 0.5 ml extraction buffer with 15 µl protease-inhibitor-mix 
(25×) and a final extraction cycle with adjacent centrifugation was executed. The resulting 
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supernatant was added to the previous one to the ultracentrifugation tubes. 
Ultracentrifugation was performed at 100000 g for 45 minutes at 4 °C under low-pressure. 
The supernatant was discarded and the pellet in 100 µl storage buffer containing 10 µl 
protease-inhibitor-mix (25×) resuspended. Samples were stored at -20 °C if not processed 
immediately.  
 
 
3.3 Enzymatic L-lactate determination 
 
To measure the L-lactate concentration in yeast medium a commercially available kit 
“Enzytec(TM) L-Milchsäure Test” (r-biopharm) was used. The manufacturers manual was 
altered for higher sample number, due to smaller sample volumes. The method underlies the 
following principles and pipetting scheme: 
 
 
L-lactate + NAD
+
 pyruvate + NADH + H
+
pyruvate + L-glutamate L-alanine + 2-oxoglutarate
L-LDH
GPT
 
Figure 3.3 | Principle of enzymatic reaction. L-lactate is oxidized to pyruvate 
while NAD+ is reduced to NADH. NADH is detected by UV absorption. 
To ensure a complete conversion and to prevent a back reaction an 
amino group is transferred from pyruvate to L-glutamate via GPT.  
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Figure 3.4 | Absorption pattern of NAD+/NADH. Generation of NADH is detected at 
340 nm. Since the reaction ratio is equimolar the L-lactate concentration 
in the sample can be calculated [R-Biopharm AG, Darmstadt]. 
 
Pipette into 96-well 
plate: 
Blank Standard Sample 
Glycylglycine Buffer #1 75.89 µl 75.89 µl 75.89 µl 
NAD solution # 2 15.18 µl 15.18 µl 15.18 µl 
GPT suspension # 3 1.52 µl 1.52 µl 1.52 µl 
Sample solution - - 75.89 µl 
Standard solution - 75.89 µl - 
Redist. Water 75.89 µl - - 
--- MIX --- ----------------------------- ----------------------------- ----------------------------- 
L-LDH solution 1.52 µl 1.52 µl 1.52 µl 
Total volume 170 µl 170 µl 170 µl 
 
Figure 3.5 | Pipetting scheme for enzymatic L-lactate determination. This 
scheme was altered from the manufacturers’ original in order to 
adopt the measurement to a 96-well plate. Before adding the LDH 
enzyme the samples had to be thoroughly mixed and incubated for 5 
minutes at room temperature. The final volumes of 170 µl lead to a 
liquid volume of 1 cm width in a single well. This allowed a direct 
calculation of the L-lactate concentration in the sample.  
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3.4 Functional characterization in yeast 
 
 
3.4.1 Phenotypic lactate uptake assay 
 
Basic principle of the lactate uptake assays was that a S. cerevisiae knock out strain was used 
which lacks endogenous lactate transporters and is therefore unable to grow on lactate as the 
sole carbon source. Introduction of an exogenous lactate transporter restores growth which is 
why this assay was used for a plasmodial lactate transporter screening.  
The yeasts were incubated at 30 °C in YPD or synthetic selective medium containing the 
appropriate nutritional requirements with 220 rpm shaking in liquid culture or on agar plates.  
In synthetic selective medium (SD) the sole carbon source was either 2% (wt/vol) glucose or 
0.25% (wt/vol) L-lactate sodium salt. Yeast from liquid cultures was harvested at the 
exponential phase of growth at an OD600 of about 0.8 washed twice with water and 
resuspended in water. The cells were now prepared for further testing depending on the 
method used. 
 
 
3.4.1.1 Agar plate assay 
 
The yeast OD600 was set to 1 (± 10%) and diluted 1:10, 1:100 and 1:1000. From this 
suspension 5 µl were pipetted onto a SD agar plate (either 2% glucose or 0.25% L-lactate) 
which was buffered with 20 mM MES, pH 5.6. The plates were incubated at 30 °C for 5-7 days. 
Results were documented. 
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Figure 3.6 | Sample application scheme for plate assay. A grid was placed 
underneath the agar plate for easier pipetting. 
 
 
3.4.1.2 Semi-quantitative liquid culture assay 
 
10 µl cell suspension at an OD600 of 2 (± 25%) were mixed with 290 µl SD medium again with 
either 2% glucose or 0.25% L-lactate as the only carbon source. The medium was buffered 
with either 25 mM succinate (for pH 5.0), 20 mM MES (for pH 6.0 and 6.5) or 50 mM TRIS (for 
pH 7.0 and 7.5). For the assay multiwell honeycomb micro plates (BioScreen Testing Services, 
Inc., Torrance, CA) were used and measured in a BioScreen C Analyzer (BioScreen Testing 
Services, Inc., Torrance, CA) for one week at an incubation temperature of 30 °C. The turbidity 
was recorded via a wide band filter (420-580 nm). 
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Figure 3.7 | BioScreen C® Honeycomb 100-well plate. According to the 
manufacturer this rather unconventional geometry provides a 
uniform temperature across all wells on a plate. Contrary to that 
more evaporation was observed at the wells on the edges and hence 
not used. 
 
 
3.4.2 Radiolabeled substrate transport assays 
 
For direct transport characterization of PfFNT, 14C-radiolabled substrate transport assays 
with different test parameters were established. 14C-carbon is an unstable isotope of carbon 
which naturally occurs on earth about one part per trillion out of all carbon in the 
atmosphere. It has a half-life of 5730 years and is radioactive, i.e. it decays into 14N through 
beta decay. 14C labeled substrates were detected in a liquid scintillation counter (figure 3.8).  
  
3   Methods 
 
 
 
45 
 
Figure 3.8 | Scheme of liquid scintillation counting. Beta rays induce light 
emission from aromatic molecules. Light pulses are amplified in a 
photomultiplier unit. The resulting current is recorded and converted 
into a spectrum. 
 
For this purpose samples were treated with scintillation cocktail which contained aromatic 
molecules that have the ability to emit fluorescence when exposed to beta particles. These 
emitted light pulses were recorded in a photomultiplier unit over a time period of 2 minutes 
and the counts per minute (CPM) were calculated. Since the exact composition of the 
scintillation cocktail differs from company to company and is kept secret, commonly used 
scintillators are shown in figure 3.9. 
 
 
O
N
CH3 CH3
PPO (2,5-diphenyloxazole) Bis-MSB (1,4-bis[2-methylstyryl]-benzene)
A B
 
Figure 3.9 | Commonly used scintillators. Molecules are drawn by Chemsketch. 
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PPO (see figure 3.9 A) is a primary scintillator, e.g. is capable of converting beta particles into 
emitted light. Since this emitted wavelength is quite narrow and with high energy (357 nm) 
the secondary scintillator bis-MSB (see figure 3.9 B) is used as a wavelength-shifter. In this 
process the first emitted fluorescence is converted into light with lower energy (420 nm) 
which is much better permeable through the plastic sample tubes and therefore gives a higher 
efficiency of counting.  
After overnight incubation in selective medium yeasts were harvested in the 
exponential phase with an OD600 of about 0.8. They were collected by centrifugation at 4000 g 
and thereafter washed with sterile water and resuspended in a buffer containing 50 mM 
HEPES/TRIS at pH 6.8 (or the indicated pH and buffer). The OD600 was set to 50 (± 10%) and 
the cells were kept on ice. In 1.5 ml reaction tubes, aliquots of yeast suspension were 
prepared and incubated for 2 minutes at 18° C immediate before each measurement. All 
experiments were performed at room temperature with at least three replicates. 
 
 
3.4.2.1 Substrate import 
 
To start the uptake assay, 80 µl of cell suspension (final OD600 40) were mixed with 20 µl 0.02 
µCi radiolabeled L-[1-14C]-lactate with a final concentration of 1 mM (or the indicated 
concentration) and 50 mM HEPES/TRIS buffer (for pH 6.8 or 7.8) or as indicated 50 mM citric 
acid/TRIS (for pH 2.8 to 4.8) or 50 mM MES/TRIS (for pH 5.8). The reaction was stopped at 
various time points by diluting with 1 ml ice cold water. The suspension was pipetted onto a 
GF/C filter membrane (WhatmanTM) and washed with 7 ml ice cold water by vacuum filtration 
(figure 3.10). The process of dilution, washing and filtration was accomplished within 10 
seconds. The filter was transferred to a scintillation vial containing 5 ml scintillation fluid 
(Quicksafe A, Zinsser Analytic GmbH, Frankfurt, Germany) and measured in a Packard Tri 
Carb liquid scintillation photometer (PerkinElmer Inc.). Always at least triplicates were 
measured. The L-lactate that was lost during the washing and filtering procedure was about 
15 % (compared to an experiment with 1 mM L-lactate solution used for dilution and 
washing) which was within the typical error margin of the method itself. 
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Figure 3.10 | Drawing of the measuring system. 100 ml Erlenmeyer flasks are 
equipped with Hirsch funnels and connected to an underpressure 
distribution device. Each flask has its own adjustable valve. 
 
 
3.4.2.2 Substrate export 
 
The 80 µl yeast suspension aliquots (final OD600 = 40) were preloaded with 20 µl 1 mM L-
lactate containing 0.02 µCi radiolabeled L-[1-14C]-lactate (or the indicated substrate). After 4 
minutes incubation the substrate uptake was stopped by centrifugation at 13500 g. Directly 
afterwards 90 µl supernatant was removed and the cells were resuspended in 1 ml 
suspension buffer (50 mM HEPES/TRIS, pH 6.8) to initiate the export measurement. At 
various time points the export was terminated by filtering the cell suspension through a GF/C 
filter membrane and washed with 7 ml ice cold water by vacuum filtration. The filter was 
transferred into a scintillation vial containing 5 ml scintillation liquid and counted in a liquid 
scintillation photometer. The exported lactate was calculated from the values of the intaken 
lactate after four minutes and the remaining lactate in the yeasts after stopping the export. All 
experiments were repeated for at least three times. There had to be made some adaptions for 
the export of D-lactate due its high metabolic rates in yeast. Therefore the temperature had to 
be lowered to 4 °C and 0.5% deoxyglucose was added to the assay buffer. Furthermore the 
preloading time of D-lactate was increased to eight minutes due to its slower transport rates. 
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3.4.2.3 Use of protonophors 
 
An essential question was if the substrate uptake into yeast was dependent on the proton 
gradient over the plasma membrane. To elucidate this, chemicals with the property to abolish 
the proton gradient were used, called “proton decouplers” or “protonophors” (mechanism of 
action see figure 3.11). 
 
 
 
Figure 3.11 | Hypothetical mechanism of action of protonophors. Weak organic 
acids are thought of being cycled through the membrane. In this 
process they are able to carry protons along a concentration gradient 
(membrane potential) at a pH which is close to their own pKa. aq = 
aqueous phase; HA = protonated acid; A- = corresponding acid anion 
[McLaughlin and Dilger, Physiol rev. 1980]. 
 
 
Since the efficiency of the protonophor depends on its pKa two different chemicals had to be 
used in order to cover the whole pH scale of interest. CCCP (carbonyl cyanide m-
chlorophenylhydrazone) was used for the pH range between 5.8 and 8.8 (figure 3.12) and 
DNP (2, 4-dinitrophenol) between 2.8 and 4.8 (figure 3.13). For the assay a 5 mM CCCP stock 
solution in 70% ethanol and a 100 mM DNP stock solution in 70% ethanol were prepared. 
Cells were incubated prior to the uptake experiment for 5 to 10 min with a final concentration 
of 50 µM CCCP or 1 mM DNP at room temperature. The lactate uptake measurement itself was 
performed as previously described in 3.4.2.1.  
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N
N
NHNH
Cl
 
Figure 3.12 | CCCP (carbonyl cyanide m-chlorophenylhydrazone) molecule. 
Drawn with ChemSketch. 
 
 
NO2
NO2
OH
 
Figure 3.13 | DNP (2,4-dinitrophenol) molecule. Drawn with ChemSketch. 
 
 
3.4.2.4 Use of DEPC 
 
In order to elucidate the role of histidine residues for the L-lactate transport in the PfFNT 
protein the effect of the histidine modifying agent DEPC (diethylpyrocarbonate) (figures 3.14 
and 3.15) on the import rates was investigated. Since DEPC is rapidly hydrolyzed in an 
aqueous environment a fresh solution in anhydrous ethanol was prepared right before each 
experiment. The stock solution was diluted in the yeast suspension to a final concentration of 
1 mM with an incubation time of 10 to 15 minutes at room temperature prior to the uptake 
assay. The lactate uptake assay was done as described in 3.4.2.1. 
 
 
O
O
O
O
OCH3 CH3 
Figure 3.14 | DEPC (diethylpyrocarbonate) molecule. Drawn with ChemSketch. 
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Figure 3.15 | Reaction of DEPC with histidine residues in a peptide. The  
π-electrons of the nitrogen atom in the pyrazole ring of histidine 
residues are attacking the carbon atom of the acid anhydride group. 
In the following reaction ethyl hydrogen carbonate is separated and 
a stable carbamate group is formed. 
 
 
3.4.2.5 Inhibitors 
 
To test the inhibitory potential of various compounds on the L-lactate uptake via PfFNT stock 
solutions were made. Depending on the solubility of the chemical they were dissolved in 
suspension buffer (pH 6.8 50 mM HEPES/TRIS), 70% ethanol or DMSO (dimethyl sulfoxide). 
The maximum concentration of DMSO in the assay never exceeded 3% and the ethanol 
concentration never 0.7%. The inhibitor stock solutions were diluted in yeast suspension to 
their final concentrations and incubated at room temperature for 10 to 15 minutes (except the 
incubation time for p-chloromercuribenzene sulfonate (pCMBS), which was 20 minutes). The 
lactate uptake assay was exerted as described previously. 
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3.4.2.6 Glycerol uptake 
 
To ascertain if an uncharged molecule similar in size with lactate and a comparable 
topological polar surface area can pass PfFNT another yeast knock out strain was used. This 
strain (By4742 fps1) lacks its endogenous aquaglyceroporin and is therefore unable to 
conduct glycerol. The measurements were carried out with the same determining factors as in 
the substrate import assay (see 3.4.2.1), e.g. OD of the yeasts, buffers, incubation time etc. The 
glycerol concentration was 1 mM with pH 6.8 and the uptake was stopped after 20 and 180 
seconds. 
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4 Results 
 
 
4.1 Development of a yeast strain devoid of lactate transporters 
 
Since the aim of this work was to elucidate a lactate transporter in the genome of Plasmodium 
falciparum a suitable test organism was inevitable. To reach this goal a Saccharomyces 
cerevisiae strain which had no endogenous lactate transporters and was therefore unable to 
grow on medium with lactate as the sole carbon source was generated. Although this objective 
was accomplished by generating BY4742Δjen1Δady2Δcyb2 LDH we used a different yeast 
strain W303-1A Δjen1 Δady2, a kind gift from M. Casal, which showed  faster growth and was 
more applicable on this account. In the beginning of this work a different intention was 
pursued: to develop a yeast strain that would produce L-lactate but at the same time was 
unable to export it. This would ultimately lead to cell death or at least a much slower growth 
rate compared to those cells that expressed a functional lactate transporter. The L-lactate 
production was controlled through a repressible MET25 promoter which regulated the 
transcription of the L-lactate-dehydrogenase gene (LDH). LDH converts pyruvate to L-lactate 
in the following reaction: 
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Figure 4.1 | Conversion of pyruvate to L-lactate via LDH. Pyruvate is reduced to 
L-lactate in a redox reaction while NADH is oxidized to NAD+. 
 
 
The reason for this intention is found in the physiological situation of the parasite. 
Plasmodium generates vast amounts of lactate during its developmental phase in the human 
red blood cells which have to be exported in order to keep the parasites viable. This metabolic 
situation was tried to copy and transfer to our test organism (figure 4.2). 
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Figure 4.2 | Scheme of genetic engineered yeast strain. This triple knock-out 
yeast is devoid of its endogenous lactate transporters and L-lactate-
dehydrogenase (as shown by red crosses). Additionally it converts 
pyruvate to L-lactate at a high rate by introduction of a plasmodial L-
lactate-dehydrogenase into its genome (red arrow). Hypothetically 
lactate could only leave the cells via a lactate transporter.  
 
 
This goal was not achieved. One possible explanation is that yeasts can cope with higher 
intracellular L-lactate concentrations by pumping them into their vacuole. This hypothesis 
was never checked. 
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Figure 4.3 | Workflow of yeast knockout. Fresh cells derived from the procedure 
of gene knockout by homologous recombination are plated onto 
selection agar. At least three selection steps are necessary to ensure that 
the derived clone is pure. The verification is done by colony PCR’s. 
Methionine suppresses L-lactate generation by the plasmodial L-LDH. 
G418 and NTC are selection marker for out knocked genes. 
 
 
The yeast double knock out strain BY4742 Δjen1Δcyb2 LDH had already been established by 
Dr. Binghua Wu in this group. In this strain the lactate transporter Jen1 and the L-lactate-
dehydrogenase cyb2 were knocked out while the plasmodial L-lactate-dehydrogenase was 
knocked in. It was the starting point to generate the triple knockout BY4742 
Δjen1Δady2Δcyb2 LDH in which additionally the second lactate transporter, Ady2, was 
knocked out. The method used was adopted from Baudin et al. (1993) and is described in 
3.1.14 using multiple selection steps with PCR verification in between (figure 4.3). One clone 
was isolated by this method and a permanent culture was generated. 
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Figure 4.4 | Colony PCR of triple knockout By 4742. The double and triple 
knockout strains show a band for the PCR-product of the selection 
marker gene. This band is absent for the wild type yeast. This indicates 
a successful knockout. WT = wild type, cyb2 = deleted cytochrome b2 
gene, ady2 = deleted acetate transporter gene, jen1 = deleted 
lactate transporter gene. 
 
 
The correct knockout of the desired genes in this clone was confirmed by colony PCR (figure 
4.4). For this, primer pairs were applied which generated positive and negative PCR products. 
The 5’ prime primer pair generated with a successful knockout a PCR product of 450 bp by 
amplification of a part of the natamycin cassette. The 3’ prime primer pair did the same by 
amplification of a 700 bp long PCR product. All other visible bands are derived by unspecific 
primer binding (bands < 2500 bp) or template DNA (smear > 2500 bp). 
 
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Figure 4.5 | L-lactate production of By 4742 knock-out strains. After overnight 
growth of these constructs the L-lactate concentration and the pH in the 
medium were determined. Lactate values are normalized to OD600= 1 to 
enable a direct comparison. WT = wild type, cyb2 = deleted 
cytochrome b2 gene, ady2 = deleted acetate transporter gene, jen1 = 
deleted lactate transporter gene, LDH = L-lactate dehydrogenase. 
 
 
To check if the engineered yeast were able to produce lactic acid medium samples were taken 
after overnight incubation. L-lactate was detected with a commercial kit, Enzytec(TM) L-
Milchsäure Test. In the buffered medium the pH was stable, without buffer it was lowered to 
pH 4. All strains with a cyb2 knockout and a LDH knock-in produced L-lactate to a certain 
amount (figure 4.5). Wild type yeast served as control and displayed no L-lactate production. 
Nevertheless there was no difference in the L-lactate concentration in the medium with yeast 
expressing lactate transporters compared to those without, e.g. strain cyb2 LDH compared 
to strain cyb2jen1ady2 LDH, in which the yeast endogenous lactate transporter Jen1 and 
the yeast acetate transporter Ady2 had been knocked out. This indicated a different transport 
mechanism over the plasma membrane than via the known yeast lactate transporters. 
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Figure 4.6 | Phenotypic lactate export assay with By 4742 strain. Medium was 
SGlc (2%) KHLU 20 mM MES pH 6.0. Yeast producing L-lactate as 
metabolic end product should show a reduced growth compared to 
wild-type yeast. All genetically altered strains and the wild type showed 
normal growth.  
WT = wild type, cyb2 = deleted cytochrome b2 gene, ady2 = deleted 
acetate transporter gene, jen1 = deleted lactate transporter gene, LDH 
= L-lactate dehydrogenase. 
 
 
To check for a reduced growth of the knockout strains a phenotypic lactate export assay was 
performed. All tested strains showed the same growth (figure 4.6). This indicated that yeasts 
are able to cope with high(er) intracellular L-lactate concentrations. It displayed that the 
modified triple knockout strain was not suitable for the intended lactate export assay.  
 
 
4.2 PfFNT gene identification 
 
Like stated previously one aim was to develop a high throughput screening assay to identify a 
lactate transporter in the genome of P. falciparum. Therefore a database was established by 
Claudia Ramisch in which putative lactate transporter encoding genes were collected for 
further investigation. The enclosure criteria were: 
 At least 400 amino acids length 
 At least 6 predicted transmembrane domains  
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The found candidates were further manually selected with the outcome of 143 putative 
lactate transporter genes which were downloaded from the PlasmoDB website 
(http://plasmodb.org/plasmo/). Two of these genes (PF3D7_0926400, previous ID PFI1295c, 
internal identification Pf70 and PF3D7_0210300, previous ID PFB0465c, internal 
identification Pf75) had already been annotated as putative lactate transporters due to a 
moderate similarity to the human monocarboxylate transporters (MCTs). The BLAST on the 
PlasmoDB site against human MCT1 generated for both genes an identity of 21%. Since 
unforeseen difficulties on the establishment of the screening assay occurred the decision was 
made to switch the aim of this thesis to the elucidation of the role of these two candidate 
genes. To accomplish this, the route of the substrate assay direction was changed from export 
to import of lactate. Although this type of assay was soon arranged no lactate transport could 
be detected via the two annotated lactate transporter genes Pf70 and Pf75. In parallel to our 
efforts a bacterial transporter called FNT (formate nitrite transporter) was shown to conduct 
lactate (Lü et al. PNAS 2012). A search of the plasmodial genome identified an FNT 
homologue, PF3D7_0316600. PfFNT has 69% sequence identity and 80% similarity to the 
formate nitrite transporter family (FNT). Although this gene product showed only a hint of 
lactate transport in our assay a second circumstance led to successful expression. To that time 
Dr. Sinja Bock was working on the expression of proteins in a cell free system. Yet, she failed 
to express PfFNT due to the typically high A and T content of P. falciparum genes [Gardner et 
al. Nature 2002]. Generation of a codon-optimized version of the gene enabled yeast 
expression of PfFNT (figure 4.7). 
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Figure 4.7 | Codon optimized PfFNT sequence. The original sequence is displayed 
in the top line, optimized bases towards the yeast codon usage are 
given in red below, and the resulting, unchanged protein sequence is 
shown in the blue bottom line. Generated with GeneArt® Gene 
Synthesis (Life Technologies) by Dr. Sinja Bock. 
 
 
The expression profile of the PfFNT gene matches quite closely the ones of the plasmodial 
hexose transporter, lactate dehydrogenase and glycolytic genes (figure 4.8).  
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Figure 4.8 | Expression profile of PfFNT (orange), plasmodial lactate 
dehydrogenase (PF13_0141, green) and metabolically 
connected enzymes during blood-stage development of P. 
falciparum. Shown are as grey thin lines the following gene 
transcripts of P. falciparum: hexokinase (gene id: PFF1155w), 
glucose-6- phosphate isomerase (PF14_0341), phosphofructokinase 
(PFI0755c), fructose-1,6- bisphosphate aldolase (PF14_0425), 
triosephosphate isomerase (PF14_0378), glyceraldehyde- 6-
phosphate dehydrogenase (PF14_0598), phosphoglycerate kinase 
(PFI1105w), phosphoglycerate mutase (PF11_0208), enolase 
(PF10_0195), and pyruvate kinase (PFF1300w). The gray squares 
show the average of the traces ± SD. Data were received from 
PlasmoDB and transcript levels are given as reads per kilobase of 
exon model per million mapped reads (RPKM). 
 
 
4.3 PfFNT expression in yeast 
Like stated above the codon optimized gene sequence of PfFNT was well expressed in S. 
cerevisiae (figure 4.9). 
  
 5 
 
 
 
         
 
Figure 4 | The expression profile of PfFNT (orange) parallels that of the plasmodial lactate 
dehydrogenase (PF13_0141, green) and the glycolytic enzymes (gray). Thin gray traces 
show expression of Plasmodium falciparum hexokinase (gene id: PFF1155w), glucose-6-
phosphate isomerase (PF14_0341), phosphofructokinase (PFI0755c), fructose-1,6-
bisphosphate aldolase (PF14_0425), triosephosphate isomerase (PF14_0378), glyceraldehyde-
6-phosphate dehydrogenase (PF14_0598), phosphoglycerate kinase (PFI1105w), 
phosphoglycerate mutase (PF11_0208), enolase (PF10_0195), and pyruvate kinase 
(PFF1300w). The gray squares indicate the average of the traces ± SD. Data were obtained 
from PlasmoDB5,6 and transcript levels are given as reads per kilobase of exon model per 
million mapped reads (RPKM)6. 
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Figure 4.9 | Western blot of PfFNT. Detected with anti-HA antibody and an 
illumination time of 10 minutes. Calculated size of the PfFNT protein is 
34 kDa. The other visible band at about 85 kDa is likely a peptide 
trimer.  
 
 
The Western blot displayed as expected no band for the empty pDR vector. Jen1 was 
expressed and showed two bands. The calculated size is about 70 kDa, which is most probably 
the upper band. The lower one might be a fragment. There was no expression for non-
optimized PfFNT, PFI1295c and PFB0465c. The optimized sequence of PfFNT lead to a strong 
protein expression with two bands, one being the monomer and the other one most probably 
the trimer.  
The optimized sequences of PfFNT, PFI1295c and PFB0465c were expressed in yeast 
and targeted to the plasma membrane. This was shown in a biotinylation assay done by Julia 
Holm-Bertelsen. 
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Figure 4.10 | Control experiment for biotinylation assay in yeast. Yeast 
protoplasts were generated which heterologously expressed a 
soluble GFP protein or a plasma membrane residing protein, 
PfAQP. They were lysed with (membrane proteins are detected) or 
without prior biotinylation (total protein detection). The 
biotinylation assay detects about 1% of intracellular, non-
biotinylated proteins. This accounts for the weak GFP signal in the 
biotinylated fraction. Moreover proteins of the plasma membrane 
are easily detected which can be seen for PfAQP in the biotinylated 
fraction. Assay was performed by Julia Holm-Bertelsen. 
 
 
Figure 4.10 illustrates that the biotinylation assay is suitable to detect membrane proteins in 
yeasts. In this method activated biotin is incubated with yeast protoplasts, e.g. cells whose cell 
wall was removed by digestion with zymolyase. Then, the activated biotin molecules bind to 
proteins that protrude from the cell membrane. Afterwards these biotinylated proteins are 
purified by binding them to streptavidin and later detected via Western blot. Two well 
characterized proteins were chosen as controls, one that is soluble and therefore accounts for 
the intracellular fraction of proteins and the other one a membrane peptide. The protein band 
of the soluble GFP was not visible in the biotinylated fraction whereas the band of the 
membrane peptide PfAQP was. The next picture illustrates that PfFNT, PFI1295c and 
PFB0465c proteins are targeted to the plasma membrane in yeast: 
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Figure 4.11 | Plasma membrane localization by biotinylation of codon-
optimized PfFNT, PFI1295c and PFB0465c in yeast. Strain 
W303-1A jen1ady2 was transformed with the displayed 
constructs. Biotinylation was carried out before detection via 
Western blot. Assay was performed by Julia Holm-Bertelsen. 
 
 
Figure 4.11 shows a weak expression profile for PFI1295c. The calculated size is about 60 
kDa. PFB0465c was expressed a bit better. The estimated size is 51 kDa. Regardless the band 
ran slightly higher that the larger PFI1295c peptide. PfFNT was well expressed as already 
seen in other Western blots. This might be a hint to the oligomerization state of the protein 
when it functionally resides in the plasma membrane. Additionally the calculated size of 34 
kDa matched the height of the band on the blot. 
 
 
4.4 PfFNT restores growth of deficient yeast strain on L-lactate 
medium 
 
This method, although originally intended as a screening assay, showed the first functional 
transport properties of PfFNT. There are two different test conditions with one in liquid 
medium and the other on solid agar plates. The yeast strain used for these assays was W303-
1A Δjen1 Δady2 which is devoid of its endogenous lactate transporters. Jen1p is a member of 
the major facilitator superfamily (MFS) and is categorized into the Sialate:H+ symporter (SHS) 
family. It is a lactate transporter with 12 transmembrane domains and is known to conduct 
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lactate, pyruvate, acetate and propionate [Soares-Silva et al. Molecular Membrane Biology 
2007]. Ady2p is a membrane protein with 6 predicted transmembrane helices which 
facilitates the transport of acetate, propionate, formate and lactate [Paiva et al. Yeast 2004]. 
The double knockout mutant strain is therefore unable to grow on medium with lactate as the 
sole carbon source [de Kok et al. FEMS Yeast Res. 2012]. 
 
 
4.4.1 Phenotypic agar plate assay 
 
First, a simple test was performed in which the lactate facilitator lacking yeast strain was 
transformed with putative lactate transporter genes and controls. Transformed yeasts were 
plated on agar with 0.25% L-lactate as the only carbon source. Result was either growth or 
not due to L-lactate uptake from the medium. The difference in growth between non- and 
codon-optimized PfFNT was obvious (figure 4.12). 
 
 
 
Figure 4.12 | Growth restoration of a lactate uptake insufficient yeast strain. 
Strain W303-1A jen1ady2 was transformed with the indicated 
constructs and plated on agar plates with synthetic defined medium 
containing L-lactate (0.25%) pH 5.6 20 mM MES. Plates were 
incubated for 1 week at 29 °C. Growth indicates L-lactate transport. 
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Strain W303-1A jen1ady2 was not able to grow due to inefficient L-lactate uptake as seen 
with the negative control, which was transformed with an empty pDR vector. Jen1 restored 
growth due to lactate facilitation as did the codon optimized PfFNT. Native PfFNT showed 
nearly no growth.  
Next, plates with three factor ten dilutions were made which allowed a first semi-
quantitative estimation of lactate transport. Additionally plates with glucose as carbon source 
served as control for detecting abnormal growth of the transformed deficient mutant strains. 
Yeast transformed with Jen1 were the positive control as they restored lactate uptake and 
with this, growth (figure 4.13). 
 
 
 
Figure 4.13 | Phenotypic L-lactate uptake assay. W303-1A jen1ady2 
transformed with the indicated genes were incubated for 5 days at 
29 °C. Agar growth medium was SDAHLW 20 mM MES with D-
glucose 2% (right side) or L-lactate 0.25% (left side) as the sole 
carbon source. (−) = empty vector as negative control; Opt. = codon 
optimized sequence of the indicated gene  
 
 
The strain with codon optimized PfFNT showed growth about ten time less than the Jen1 
strain. Both native and codon optimized genes of annotated plasmodial MCTs presented no 
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better growth than the negative control. All yeast strains displayed normal growth on glucose 
medium (figure 4.13). 
 
 
4.4.2 Semi-quantitative liquid culture assay 
 
The principles of this assay are the same as for the agar plate assay but a liquid medium was 
used instead of solid medium allowing for more quantitative growth evaluation. Growth was 
monitored with a Bioprofile machine which detected the OD600 of the cultures at various time 
intervals (mostly every 30 minutes) in 200 well plates. Moreover it was much easier to test for 
different pH conditions. From the monitored growth curves the area under the curve (AUC) 
was calculated. 
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Figure 4.13 | Liquid phenotypic lactate uptake assay. Growth curves of W303-1a 
ja strain at pH values from 4 to 8. Cells were incubated for one week 
with buffer containing L-lactate as the sole carbon source at 30 °C. The 
turbidity was recorded in a BioScreen C Analyzer®. For better 
comparison the AUC for 160 hours was calculated. Colors: blue = no 
protein, green = Jen1, orange = PfFNT 
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Growth of yeasts expressing PfFNT as the only lactate transporter is pH dependent as shown 
in figure 4.13. Since L-lactate was the sole carbon source in this experiment growth of cells 
implicated lactate transport. Cells without expression of a lactate transporter (blue) showed 
no growth at any pH. At pH 4 the highest ODs were measured and the curves of Jen1 (green) 
and PfFNT (orange) showed staedy growth over the whole timescale. This is reflected in high 
AUC values for pH 4. Growth of the strains with a functional lactate transporter is very similar 
at pH 5 and 6. Here a plateau phases is reached after about 90 hours.  At pH 7 and 8 there was 
no growth detectable. 
 
 
4.5 PfFNT radiolabeled substrate transport characterization in yeast 
 
For direct transport characterization of PfFNT various 14C-radiolabled substrate transport 
assays were established.  
 
 
4.5.1 Setting the assay parameters  
 
Since the assay had to be established first its basic parameters were set. 
 
 
4.5.1.1 Optimal yeast OD600 determination 
 
L-lactate uptake was tested with yeast suspensions resulting in final OD600 of 20, 40 and 80. 
Surprisingly there was no difference in the amount of radiolabel taken up between the 
different OD600 besides a higher error of the OD600 80 samples (figure 4.14). Furthermore it 
was more difficult to accurately pipette a yeast suspension with OD600 80 since it was more 
viscous. Therefore the decision was made to use an OD600 of 40 for the assay. 
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Figure 4.14 | Influence of OD600 on radiolabel uptake in yeast. Strain W303-1A 
jen1ady2 was incubated at OD600 20, 40 and 80 at room 
temperature with 1 mM L-lactate buffer pH 6.8 for up to ten minutes. 
Jen1 was the positive control since it is the endogenous yeast lactate 
transporter and the empty pDR vector (-) served as the negative 
control. 1 time point includes 2 samples and error bars indicate the 
difference between the 2 values. Note that the ordinate scale of OD600 
80 is altered as indicated by an exclamation point.  
 
 
 
 
4   Results 
 
 
 
71 
4.5.1.2 Determination of yeast suspension and buffer mixing ratio  
 
Four different mixing ratios and their implication on repeatability were tested. The optimum 
ratio was found to be 1:5 which was a compromise between complete and fast mixing and 
viscosity of the suspension before mixing the two liquids (figure 4.15).  
 
 
 
Figure 4.15 | Influence of yeast suspension to buffer ratio for mixing. Strain 
W303-1A jen1ady2 PfFNT was incubated at OD600 40 at room 
temperature with 1 mM L-lactate buffer pH 6.8 for ten minutes. The 
bars show the difference between two values as percentage. The 
arrow indicates rising viscosity of the yeast suspension before mixing. 
 
 
4.5.1.3 Radioactive 14C quantity per sample  
 
The influence of the amount of radiolabel per sample was tested. For this radioactivity was 
doubled from 0.02 to 0.04 µCi. This resulted in a about twice better resolution (figure 4.16). 
Nevertheless, a major point in the use of radioactive chemicals is to keep the environmental 
pollution at a minimum. Therefore the aim was to use as less radioactivity per sample as 
possible while keeping the signal to noise ratio at a satisfactory level, i.e. about 5:1. This was 
achieved with 0.02 µCi (740 Bq) per sample for a substrate concentration of 1 mM.  
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Figure 4.16 | Amount of radioactivity per sample and its impact on the signal to 
noise ratio. Strain W303-1A jen1ady2 was incubated at OD600 40 at 
room temperature with 1 mM L-lactate buffer pH 6.8 containing either 
0.02 or 0.04 14C per sample. Measuring time was 20 seconds. The 
empty vector served as negative control (-). One time point includes 3 
samples and error bars indicate standard deviation. 
 
 
4.5.2 Substrate import kinetics 
 
Although faster and more convenient to handle, the import of radiolabeled substrates does 
not reflect the physiological situation of the parasite while it resides in the host erythrocytes. 
Nevertheless, it was a valuable tool to get insight into transport kinetics and characteristics, 
e.g. the profile of facilitated substrates.  
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Figure 4.17 | Control for L-lactate import kinetic characterization in yeast. 
Strain W303-1A jen1ady2 was incubated at room temperature 
with 1 mM L-lactate buffer at pH 6.8 for up to 10 minutes. Jen1 was 
the positive control since it is the endogenous yeast lactate 
transporter and the empty pDR vector (blue) served as the negative 
control. One time point includes 3 to 6 samples and error bars 
indicate SEM. Uptake rates were normalized to 1 mg dry yeast. 
 
 
Yeast were transformed with several constructs and tested on their L-lactate transport 
kinetics. The empty vector as negative control exhibited a very low background and therefore 
proofed this test system as very suitable (figures 4.17 and 4.18).  
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Figure 4.18 | Kinetic characterization of L-lactate transport of PfFNT, PFI1295c 
and   PFB0465c. Strain W303-1A jen1ady2 was incubated at room 
temperature with 1 mM L-lactate buffer at pH 6.8 for 10 minutes, 
respectively for up to 2 hours in the case of PFI1295c and PFB0465c. 6 
measurements contributed to 1 sample and error bars indicate SEM. 
 
 
Unsurprisingly Jen1 displayed the highest lactate facilitation rates (see figure 4.17) since it is 
the native lactate transporter in yeast. The codon optimized PfFNT construct showed with 
0.25 nmol  mg-1  min-1 similar initial lactate import rates to Jen1. After 4 minutes lactate 
uptake was saturated (the same was observed for E. coli FocA (figure 4.31)). Transport 
increased linearly with the L-lactate concentration throughout the physiological, low-
millimolar range and saturated above 50 mM. An apparent L-lactate affinity of 87 mM for 
PfFNT was found. This value strongly depends on the prevailing pH. When the external pH 
was shifted from 6.8 to 4.8, the affinity of PfFNT for lactate increased 5-fold to 17 mM whereas 
the maximal transport rate remained unchanged at 14 nmol  mg–1  min–1 (figure 4.19). 
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Figure 4.19 | Concentration dependency of PfFNT lactate transport. Strain 
W303-1A jen1ady2 was incubated at room temperature with 1 to 
maximum        150 mM L-lactate buffer for 20 seconds at pH 6.8 and pH 
4.8, respectively. Error bars denote SEM of 3 measurements.  
 
 
Since the two annotated MCT-like plasmodial lactate transporters (PFI1295c and   PFB0465c) 
showed less expression than PfFNT in Western blots (figure 4.11) the time for lactate uptake 
was increased up to 2 hours. The idea was to compensate the lower expression levels of the 
two proteins by a higher exposure time. This was possible since the test system showed 
nearly no background lactate uptake. But even under prolonged incubation in lactate buffer 
there was no radiolabeled lactate uptake detectable for the codon-optimized sequences of 
PFI1295c and PFB0465c (figure 4.19). This was also the case for PfAQP. It exhibited after 1 
hour an L-lactate uptake of 0.03 ± 0.007 nmol  mg-1 which equates the average background 
uptake of the negative control (data not shown). 
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Figure 4.20 | Substrate selectivity profile of PfFNT. Strain W303-1A jen1ady2 
was incubated at room temperature with 1 mM buffer of the 
respective substrate at pH 6.8 for 20 seconds to ensure true initial 
transport rates. 3 measurements contributed to one sample and error 
bars indicate SEM. Orange = PfFNT; blue = empty vector 
 
 
The substrate selectivity of PfFNT is displayed in figure 4.20. Highest rates were obtained with 
acetate followed by formate. The affinity for lactate was about half of these values while there 
was little difference between the two enantiomers, reflecting the physiological situation of the 
parasite. Pyruvate is transported at about half of the rate of L-lactate while the dicarboxylate 
malonate is not facilitated via PfFNT. 
For testing glycerol uptake S. cerevisiae strain BY4742 Δfps1 was used which lacks its 
endogenous glycerol transporter.  
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Figure 4.21 | Glycerol uptake into yeast. Strain BY4742 Δfps1 lacks its endogenous 
glycerol facilitator. Uptake was recorded over 180 seconds at room 
temperature with 20 mM glycerol buffer at pH 6.8. Error bars 
represent SEM resulting from 3 samples.  
 
 
Glycerol is not a substrate of PfFNT. This was proved by radiolabeled glycerol uptake into 
yeast deficient of their endogenous glycerol facilitator. There was no difference between cells 
expressing PfFNT and the negative control (empty vector). A known glycerol channel, PfAQP, 
showed a twice-higher uptake of glycerol than the other two constructs (figure 4.21). 
 
 
4.5.3 Substrate export kinetics 
 
The substrate export is compared to the natural situation of the blood stage parasites the 
more valuable test condition. Plasmodia need to get rid of vast amounts of lactic acid while 
they reside inside the red blood cells of their hosts. For this they export lactic acid derived 
from glycolysis out of their cells via the host cell ultimately into the blood serum. This 
situation is mimicked in this method. Nevertheless it was not used as the standard method 
due to a much longer sample preparation and overall assay time compared to the import 
assay. 
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Figure 4.22 | Monocarboxylate export via PfFNT. Strain W303-1A jen1ady2 
was incubated at room temperature with 1 mM monocarboxylate 
buffer at pH 6.8. To begin efflux the external solution was diluted 
100fold by addition of monocarboxylate-free buffer. In order to 
compensate for variations in cell loading the amount of intracellular 
monocarboxylate was normalized. If not indicated, substrate efflux 
was measured at room temperature. 
 
 
PfFNT L-lactate export followed the same time dependence as the import with saturation of 
efflux after 4 minutes (figures 4.18 and 4.22) at room temperature. D-lactate displayed no 
efflux due to rapid metabolism by three D-lactate dehydrogenases in S. cerevisiae (DLD 1-3). 
Therefore it was furthermore analyzed at 0°C to lower the metabolic activity of the 
dehydrogenases to a minimum. This was not necessary for the L-enantiomer since the 
endogenous yeast L-lactate dehydrogenase was mostly down regulated by reason of the 
culture conditions in high glucose. Formate is not a metabolic precursor in yeast and could be 
measured at room temperature as well. It was facilitated with similar properties to L-lactate 
(figure 4.22). The amount of remaining monocarboxylates in the cells after the assay was 
probably because of trapping by metabolic conversion and compartmentalization. 
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Figure 13 | Monocarboxylate transport in the efflux direction of jen1∆/ady2∆ yeast (15) 
expressing PfFNT. Yeast cells were preloaded in 1 mM monocarboxylate solution containing 
radiolabeled 14C-monocarboxylate. To initiate efflux the external solution was diluted 100fold by 
addition of monocarboxylate-free buffer at 18°C. The amount of intracellular monocarboxylate 
was normalized to compensate for variations in cell loading. D-lactate was additionally analysed 
at 0°C to inhibit the metabolic activity of the three endogenous D-lactat  dehydrogenases. The 
endogenous yeast L-lactate dehydrogenase is largely downregulated due to the culture 
conditions in high glucose, and formate is not a metabolic precursor in yeast. The portion of 
monocarboxlates remaining in the cells after the assay is likely due to trapping by metabolic 
conversion and compartmentalization. 
 
 
 
 
         
 
Fig. 14 | Blockage of the proton/potassium antiporter does not affect L-lactate uptake via 
PfFNT. The yeast potassium/proton antiporter represents a putative alternative proton uptake 
pathway. Yet, despite compensation of the transmembrane potassium gradient the rate of L-
lactate uptake remains stable (#: no significant difference according to Student’s t-test). 
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4.5.4 pH dependency 
 
To get more insight into the mode of PfFNT transport, specifically whether it would be proton 
linked or not, pH dependence of substrate facilitation was investigated.  
 
 
 
Figure 4.23 | pH-dependency of L-lactate transport via PfFNT. Strain W303-1A 
jen1ady2 was incubated at room temperature with 1 mM L-lactate 
buffer at the given pH’s. Error bars donate SEM of 3 measurements. 
Orange = PfFNT; blue = empty vector 
 
The transport rate of lactate increased with lowering the pH (figure 4.23) until the pKa of 
lactic acid was reached (pKa lactic acid = 3.9). At this pH lactate and lactic acid are equimolar. At a 
pH below 3.9 transport rates dropped indicating that the anionic species is needed for 
transport rather than the protonated lactic acid. 
 
 
pH = p𝐾𝑎 +  𝑙𝑜𝑔10 (
[𝐴−]
[𝐻𝐴]
) 
Formula 4.24 | Henderson-Hasselbalch equation. [HA] is the molar concentration 
of the undissociated acid and [A-] is the concentration of the 
deprotonated conjugated base. pKa is – log10 (Ka) with Ka being the 
acid dissociation constant. 
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The Henderson-Hasselbalch equation can be transposed to the following formula: 
 
𝐴− = 𝐻𝐴 ∙  10𝑝𝐻−𝑝𝐾𝑎  
This allows calculating the ratio of the protonated acid to anion at a defined pH. If the ratio is 
considered and integrated into the pH dependency curve the following graph results: 
 
 
 
Figure 4.25 | L-lactate transport after correction for the pH-dependent 
lactate/lactic acid ratio. The Henderson-Hasselbalch equation 
was applied and the percentage of the lactate anion at the displayed 
pH was calculated. The pH curve (figure 4.23) was then corrected 
for these values. 
 
 
The corrected values showed a linear correlation between the proton concentration, e. g. pH, 
and the transport rate of L-lactate (figure 4.25). This finding hints towards a proton/lactate 
symport. 
 
 
4.5.5 Use of protonophors 
 
To test the assumption made above, protonophors were employed. Protonophors are weak 
organic acids that are able to abolish the proton gradient over the plasma membrane. As 
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described in the methods section (see 3.4.2.3) two different protonophors were used, CCCP 
and DNP, with different pKa values. 
 
 
 
Figure 4.26 | Proton gradient decoupling by protonophors. W303-1A 
jen1ady2 yeast were used. Shown is the effect of CCCP and DNP at 
the respecting pH’s. Errors bars denote SEM of triple determinations. 
Orange = PfFNT; blue = negative control 
 
 
The transport of PfFNT dropped to rates close to the empty vector negative control when DNP 
(pH 2.8 to 4.8) or CCCP (pH 5.8 to 7.8) were employed (figure 4.26). This indicates a proton 
motive force in the lactate facilitation via PfFNT. 
 
 
4.5.6 Medium alkalization during L-lactate uptake via PfFNT  
 
Uptake of L-lactate into yeast cells coincided with alkalization of the weakly buffered external 
medium. This happened in a concentration dependent manner directly showing 
lactate/proton co-transport (figure 4.27). 
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Figure 4.27 | pH change during substrate transport via PfFNT. The external 
buffer was alkalized due to lactate/proton symport in PfFNT 
expressing yeast (W303-1A jen1ady2) at different inward 
directed L-lactate gradients. The inset depicts the initial, 
concentration-dependent proton uptake kinetics. Blue = non-
expressing control, orange = PfFNT, L-lactate concentration: circles = 
10 mM, diamonds = 20 mM and triangles = 40 mM; performed by Dr. 
Binghua Wu  
 
 
When the L-lactate concentration was doubled from 10 to 20 mM or 20 to 40 mM respectively, 
the alkalization rate was doubled also (figure 4.27, small insert). With the empty vector 
control there was no change in pH detectable.  
 
 
4.5.7 Blocking the yeast potassium/proton antiporter 
 
S. cerevisiae is capable of maintaining its cytosolic pH via various mechanisms. One of these 
are proton-potassium-antiporters (figure 4.28). To exclude the possibility that protons took 
the alternate route in exchange to potassium ions into the cells through proton-potassium-
antiporter the potassium concentration in the test buffer was raised.  
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Figure 4.28 | Model for pH homeostasis in yeast. S. cerevisiae has numerous 
different mechanisms to sustain a stable intracellular pH. One of these 
is the Nha1 potassium / proton antiporter which resides in the 
plasma membrane. It exchanges protons for potassium ions. 
[Martínez-Muñoz et al. JBC 2008] 
 
 
An increased external potassium concentration did not affect the L-lactate transport rate. This 
was tested by the use of 40, 80 and 120 mM potassium in the test buffer. L-lactate 
concentration was 1 mM and the pH 6.8 (figure 4.29). 
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Figure 4.29 | Blocking the proton/potassium antiporter has no effect on L-
lactate uptake in yeast. Strain W303-1A jen1ady2 was 
incubated at room temperature with 1 mM L-lactate buffer at pH 6.8 
containing the shown potassium concentrations. The alternative 
proton uptake pathway via Nha1 is inhibited by high external 
potassium concentrations. Nevertheless the rate of L-lactate uptake 
remains stable (#: no significant difference according to Student’s t-
test). Errors bars denote SEM of triple determinations. 
 
 
4.5.8 Inhibitors that reduce lactate transport via PfFNT 
 
To get an idea of the physiological relevance of PfFNT in living plasmodia inhibitors with 
known antimalarial activity were tested. The compounds used were furosemide, phloretin, 
pCMBS and derivatives of cinnamic acid which is a known inhibitor of lactate transporters 
(figure 4.30).  
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Figure 4.30 | Inhibition of PfFNT L-lactate transport. Strain W303-1A 
jen1ady2 was incubated at room temperature for 10 to 15 
minutes in storage buffer at pH 6.8 containing the respective 
inhibitor in its final concentration. Directly afterwards transport 
rates with 1 mM L-lactate were recorded. Phloretin (a), furosemide 
(b), cinnamic acid derivatives (c, d, and g) and L-lactate derivative 
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inhibit PfFNT, neutral cinnamamide (e) and pCMBS do not (f). 
Errors bars denote SEM of triple determinations. 
 
 
For all compounds with an inhibitory effect the activity-curves looked very similar with slight 
differences in the maximum effect, being around 40% remaining activity. These compounds, 
except 3-phenyl-L-lactate, had an IC50-value of about 1 mM. Since the substrate, L-lactate, was 
applied in a concentration of 1 mM it is likely that all substrates inhibited transport in a 
competitive mode. 3-phenyl-L-lactate had a maximum inhibitory effect of about 65% 
remaining activity at 3 mM. The tested concentrations reached from 10 µM to 3 mM. Phloretin 
and pCMBS had to be, due to poor solubility, dissolved in DMSO. This had an inhibitory effect 
of about 10% on its own. This value was subtracted from the obtained data. Cinnamamide and 
pCMBS had no effect on the L-lactate transport rates via PfFNT. The highest inhibitory effect 
was reached with -fluorocinnamic acid and was 35% activity at 3 mM. 
 
 
 
Figure 4.31 | Lactate transport via E. coli FocA is inhibited by α-
fluorocinnamate. Strain W303-1A jen1ady2 was employed 
and FocA tested exactly as previously PfFNT. 1 mM L-lactate at pH 
6.8 was used for the uptake curve (a) and inhibition by α-
fluorocinnamate (b). Error bars indicate SEM for 3 measurements. 
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Figure 4.31 displays kinetics of L-lactate transport through EcFocA. The uptake rate is 
similar to PfFNT while α-fluorocinnamate is less effective on FocA (55% activity 
versus 35% activity in PfFNT). Nevertheless this experiment might point to an 
antibiotic potential of cinnamic acid derivatives. 
 
 
4.6 Altering the crucial pore lining amino acids of PfFNT 
 
First attempts to elucidate the exact mechanism of transport of lactate through the pore of 
PfFNT were made. For this, mutations of expected crucial pore lining amino acids were made 
to see whether alterations in size or polarity would have an effect on the transport.  
Three constructs were derived: 
 
 Threonine 106 to serine 
 Threonine 106 to valine 
 Histidine 230 to phenylalanine 
 
All constructs were successfully mutated, sequenced and cloned. Nevertheless only the T106V 
and T106S mutants were tested in the radiolabeled L-lactate transport assay due to time 
limitations (figure 4.32). 
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Figure 4.32 | Kinetic characterization of L-lactate transport via T106S and 
T106V. Strain W303-1A jen1ady2 was incubated at room 
temperature with 1 mM L-lactate buffer at pH 6.8 for up to 10 
minutes. 3 measurements contributed to 1 sample and error bars 
indicate SEM. 
 
 
The threonine to serine mutant showed an about 50% reduced L-lactate transport rate 
compared to the wild type PfFNT. But there was no lactate transport detectable with the 
threonine to valine mutant. This gives an impression of the importance of a hydrogen bond 
interaction partner at the position 108 in the protein. 
 
 
4.7 The PfFNT-GFP fusion protein is targeted to the parasite plasma 
membrane 
 
The idea was in order to gain insight into the relevance of PfFNT for living parasites to 
perform direct radiolabeled L-lactate uptake measurements on permeabilized infected RBCs. 
For this the PfFNT gene was cloned into a plasmodial vector. P. falciparum 3D7 were 
transfected to overexpress the protein. This was confirmed by confocal fluorescence 
microscopy since the construct contained a GFP at the C-terminus. Alexandra Blancke-Soares 
in the group of Tobias Spielmann took pictures (figure 4.33) which clearly show expression 
and targeting of PfFNT into the plasma membrane of the parasites. 
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Figure 4.33 | Visualization of PfFNT in infected erythrocytes. a. Fluorescence 
emission of living, PfFNT-GFP expressing early (top panel) and late 
trophozoites (bottom panel) within erythrocytes. DIC, differential 
interference contrast; DAPI (blue), nuclear stain; GFP (green). b. A 
single confocal section through an infected RBC. Bodipy-TX-ceramide 
(red), lipid membrane stain. c, d. Co-localization of PfFNT-GFP with 
merozoite surface protein 1 (MSP1) in the plasma membrane by 
fluorescence microscopy (c) or a single confocal section (d) using 
anti-GFP and anti-MSP1 antibodies. Scale bars indicate 5 μm. 
 25 
        
 
 
Figure 4 | Localization of PfFNT in fected erythrocytes. a. Fluorescence pattern of live, 
PfFNT-GFP expressing early (top panel) and lat  t phozoites (bottom panel) within 
erythrocytes. DIC, differential interference contrast; DAPI (blue), nuclear stain; GFP (green). b. 
A single confocal section through an infected erythrocyte. Bodipy-TX-ceramide (red), lipid 
membrane stain. c, d. Co-localisation in the plasma membrane of PfFNT-GFP with merozoite 
surface protein 1 (MSP1) by fluorescence microscopy (c) or a single confocal section (d) using 
anti-GFP and anti-MSP1 antibodies. Scale bars: 5 µm. 
 
 
 
4   Results 
 
 
 
90 
The PfFNT-GFP fusion construct showed a clear staining of the plasma membrane of 
plasmodium. Nuclei were marked with DAPI which resulted in a blue staining. For lipid 
membrane staining the dye Bodypi-TR-C_5-ceramide was used which is illustrated in red 
color. As controls, antibodies were used which were directed against the membrane residing 
peptide MSP1 and GFP. A merge of these markers with PfFNT resulted in a yellow color when 
both proteins co-localized.  
Although first radiolabeled substrate measurements in P. falciparum seemed to be quite 
promising the obtained data could not be repeated and are therefore not shown. 
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5 Discussion 
 
 
The aim of this thesis was to elucidate and characterize the protein that is responsible for 
lactate transport out of the malaria causing parasite Plasmodium falciparum. This is of special 
importance because this target has escaped elucidation since the first reports on lactate 
production in plasmodia emerged over 60 years ago [McKee et al. J Exp Med. 1946]. 
Furthermore, the last publication on this topic was published 13 years ago [Elliott et al. 
Biochem J. 2001] and until then no new knowledge on that topic was released. This fact is 
surprising since lactate is known to be the metabolic end product of plasmodium while it 
resides in the red blood cells of its host [McKee et al. J Exp Med. 1946]. Moreover there is 
evidence that blockage of this pathway would highly stress or even kill the parasite [Cranmer 
et al. J Biol Chem. 1995]. The lactate permease might therefore be a valuable drug target 
[Elliott et al. Biochem J. 2001].   
At the beginning the aim was to mimic the physiological situation of the parasite while it 
resides inside the host erythrocytes. During this phase there are two striking characteristics 
that reflect the situation of the parasite inside the RBC (figures 5.1 and 5.2): 
 
 Generation of vast amounts of lactate (18 mmol • l–1 • min–1) [Ginsburg Trends 
Parasitol. 2002] 
 Need for export of lactate and protons, generated by glycolysis [Ginsburg Trends 
Parasitol. 2002] 
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Figure 5.1 | Glucose degradation of P. falciparum inside the red blood cell. D-
glucose is anaerobically metabolized by glycolysis to pyruvate. In order 
to restore two redox equivalents pyruvate is further reduced to L-
lactate. This metabolic end product is exported through an until then 
unknown transporter. HT = hexose transporter; LDH = L-lactate 
dehydrogenase 
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Figure 5.2 | Simplified scheme of carbon transport- and metabolic-processes of 
the infected erythrocyte. Abundant glucose is taken up from the host 
serum via the human glucose transporter (GLUT1) and the plasmodial 
hexose transporter (PfHT). Once inside the parasite it is converted via 
anaerobic glycolysis to lactate. Lactate as the metabolic end product is 
exported together with protons in a 1:1 stoichiometric manner via 
PfFNT and the human monocarboxylate transporter (MCT1).  
 
 
In order to reflect this situation a yeast strain BY4742 Δjen1Δady2Δcyb2Δadh1 LDH was 
engineered, producing L-lactate with no export pathway apparent. The strain produced high 
amounts of L-lactate. Nevertheless there was no difference between yeasts expressing lactate 
transporters and those without (figure 4.5). Most likely the yeasts shuffle the produced lactate 
into their vacuoles and accordingly are able to cope with the, compared to wild type yeast, 
abnormal high concentrations. 
Therefore the assay direction was changed from export to import. Lactate permeases 
from different species are known to show bidirectional facilitation of substrates, e.g. the 
monocarboxylate transporters 1 to 4 of mammals [Halestrap et al. IUBMB Life 2012], formate 
nitrite transporters of bacteria [Lü et al. Biol. Chem. 2013] and the pyruvate transporter in 
Trypanosoma brucei [Sanchez J Biol Chem. 2013]. The yeast based test system (strain W3031A 
jen1ady2) had the advantage of a nearly absent background substrate transport compared 
to control cells. Moreover the sequence optimized PfFNT led to a strong protein expression in 
yeast. Western blots performed by Marie Wiechert and Julia Holm-Bertelsen showed multiple 
bands, ranging from monomers and trimers up to pentamers (Identity of a Plasmodium 
lactate/H+ symporter structurally unrelated to human transporters, Rambow et al. currently 
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under revision). All tested proteins were well expressed in the yeast system and integrated 
into the plasma membrane. This was confirmed by a biotinylation assay performed by Julia 
Holm-Bertelsen (figures 4.10 and 4.11). 
 
 
5.1 Putative plasmodial MCT’s 
 
At the beginning it was investigated whether two plasmodial monocarboxylate transporter 
candidates would conduct lactate. These putative lactate permeases had been annotated 
reasoned by a certain degree of sequence similarity (about 30%, figure 5.3) and analogous 
predicted membrane topology to MCT’s (figures 5.4 and 5.5).  
 
 
Figure 5.3 | Identity and similarity between the proteins of MCT’s, PFI1295c 
and PFB0465c. TeXshade [Beitz Bioinformatics 2000] was used to 
visualize the data generated from the sequence alignment (figure 5.6). 
 
 
To date only MCT1-4 have been shown to carry monocarboxylates. They transport important 
metabolic compounds such as lactate, pyruvate and ketone bodies in a proton-coupled fashion 
[Halestrap Mol Aspects Med. 2013]. They share characteristic sequence motifs, which were 
confirmed by labeling studies and proteolytic digestion [Halestrap Mol Aspects Med. 2013]. 
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Figure 5.4 | Predicted membrane topology of human MCT1. It is built of 12 
transmembrane helices with intracellular C- and N-termini and a large 
intracellular loop between helices 6 and 7 (Halestrap et al. Biochem. J. 
1999). 
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Figure 5.5 | Predicted topology of PFI1295c (b) and PFB0465c (a). The topology 
plots are based on the sequence alignment shown in figure 5.6 and 
were set using TeXtopo [Beitz Bioinformatics 2000]. 
 
Although there is a certain degree of apparent resemblance in the predicted topology of 
PFI1295c, PFB0465c and MCT1 the alignment of the candidates with the SLC16 members 
shows absence of crucial residues for transport. These amino acids are conserved throughout 
MCT1 – 4. They reside in transmembrane span 1 (lysine) and in span 8 (aspartate and 
arginine) (figure 5.6). 
 4 
a
 
b 
 
 
 
Figure 3 | Topology predictions of PFB0465c (a) and PFI1295c (b). The topology plots are 
based on the sequence alignment shown in Supplementary Figure 1 and were set using 
TeXtopo
4
. 
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Figure 5.6 | Alignment of human MCT 1 to 13 with PFI1295c and PFB0465c. The 
alignment was created using the clustalw algorithm and envisioned 
using TeXshade [Beitz Bioinformatics 2000]. Positions with conserved 
residues throughout are colored yellow on purple and respectively 
identical and similar residues are shaded in blue and magenta. The 
roman letters and bars symbolize the regions of the proposed MCT1 
transmembrane spans. The green diamonds in transmembrane spans 1 
and 8 mark the positions of a conserved lysine, an aspartate, and an 
arginine, which have been shown to be required for hMCT1 
functionality; none of these are present in the plasmodial peptides. 
 
 
But there are more arguments against a role in lactate facilitation of the putative plasmodial 
MCTs. For instance when the expression levels of these peptides are considered (figure 5.7). 
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Figure 5.7 | Expression profile of the putative plasmodial MCT’s during 
development inside the RBC. Green = plasmodial hexose 
transporter; purple = PFB0465c; red = PFI1295c; orange = PfFNT. 
Data were from PlasmoDB and transcript level is set as reads per 
kilobase of exon model per million mapped reads (RPKM) [Bártfai et 
al. PLoS Pathog. 2010].  
 
 
In the early trophozoite-phase (about 20 hours past invasion) the parasites exhibit a strong 
metabolic activity due to their rapid growth [Roth Blood Cells 1990; Olszewski et al. Mol. 
Biochem. Parasitol. 2011]. This is reflected by high expression levels of glycolytic enzymes, 
such as glucose-6-phosphate isomerase (PF14_0341), and the hexose transporter (PFB0210c) 
(figure 5.7). At that stage PfFNT is expressed at levels comparable to the hexose transporter 
whereas PFI1295c and PFB0465c levels are low (about 4 times less) with maximum 
expression at the late schizont stage (40 hours post invasion). This indicates a different role of 
these two proteins other than lactate export, which would give an explanation why there was 
no lactate facilitation for PFI1295c and PFB0465c detectable. It was shown that the peptides 
were expressed in our test organism S. cerevisiae and integrated into the plasma membrane 
(figure 4.11). Anyway growth was not restored in the yeast phenotypic L-lactate uptake assay 
by the two candidates and there was also no radiolabeled substrate facilitation detectable, 
even under a prolonged uptake time (figure 4.18). In the end this fact is not surprising since a) 
the expression profile of these peptides misfits the plasmodial development inside the red 
blood cells (figure 5.7) and b) the deficiency of functionality may be credited to the absence of 
three conserved residues in transmembrane spans 1 and 8, which have been shown to be 
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essential for lactate transport by MCT1 (figure 5.6) [Halestrap Mol. Aspects Med. 2013]. 
Together with the fact that until now functional MCTs are found exclusively in mammals 
allows the assumption that the role as lactate transporters of this family was established later 
in evolution. For example the yeast S. cerevisiae encodes for five MCT like proteins, yet for 
none of these lactate facilitation could be demonstrated [Makuc et al. Yeast 2001]. The exact 
function of PFI1295c and PFB0465c remains to be elucidated.  
Furthermore, data on aquaporins that are able to channel lactate were published 
[Tsukaguchi et al. J Biol Chem. 1998; Choi et al. J Biol Chem. 2007; Bienert et al. Biochem J 2013; 
Faghiri PLoS One 2010; reviewed in Rambow et al. Front. Pharmacol. 2014]. Therefore the 
plasmodial aquaporin PfAQP was checked for lactate conductance. The assay parameters were 
the same as for the PFI1295c and PFB0465c radiolabeled L-lactate uptake measurements with 
a prolonged time. There was no lactate facilitation via PfAQP detectable underlying the 
important role of PfFNT for lactate detoxification due to virtually absent further candidates 
that could be supportive regarding this matter.  
 
 
5.2 Origin and classification of PfFNT 
 
In the genome of P. falciparum is a single putative formate nitrite transporter sequence found. 
Its expression profile matches the plasmodial glycolytic enzymes as well as the glucose 
transporter (figure 5.7). A BLAST search yielded throughout the Plasmodium ssp. one FNT 
gene each, with high identity (about 70%) between the sub species and a high similarity to the 
bacterial FNTs (>40%) (figures 5.8 and 5.9).  
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Figure 5.8 | Phylogenetic classification of PfFNT. Within the Plasmodium ssp. (Pb = 
P. berghei; Py = P. yoelii; Pc = P. chabaudi; Pk = P. knowlesi) persists a 
high degree of similarity and identity. To the bacterial FNTs (Ec = 
Escherichia coli; St = Salmonella typhimurium, Cd = Clostridium difficile) 
exists a minor relationship of PfFNT, nevertheless with about 40% of 
similarity.  
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Figure 5.9 | Sequence alignment of FNT peptides in plasmodia and bacteria. The 
alignment was created using the clustalw algorithm and visualized using 
TeXshade [Beitz Bioinformatics 2000]. Positions with conserved residues in 
all sequences are highlighted yellow on purple; identical and similar 
residues are colored in blue and magenta, respectively. Helical domains 
according to the E. coli FocA crystal data [Wang et al. Nature 2009] are 
numbered consecutively. The positions of the helix-interrupting loops L2 
and L5 (figure 5.10) are indicated by bars. The plasmodial FNT proteins lack 
apparent cell export signals [Heiber et al. PLoS Pathog. 2013]. 
 6 
  
 
 
Figure 5 | Sequence alignment of plasmodial and bacterial FNT proteins. The alignment 
was generated using the clustalw algorithm and visualized using TeXshade1. Positions with 
conserved residues in all sequences are colored yellow on purple; identical and similar residues 
are shaded in blue and magenta, respectively. Helical domains according to the E. coli FocA 
crystal data7 are numbered consecutively. The positions of the helix-interrupting loops L2 and 
L5 (see Supplementary Figure 7) are indicated by bars. The plasmodial FNT proteins lack 
apparent cell export signals
8
. 
5   Discussion 
 
 
 
104 
An indication that PfFNT plays a crucial role in the parasitic carbon metabolism is the high 
expression level during maturation of the parasites (figure 5.7). Furthermore it is most 
probably the only protein (non functional MCT like peptides and non conductive PfAQP for 
lactate) that is capable of coping with export of metabolic end products, i.e. lactate.  
Generally FNTs, which are found exclusively in lower organisms, such as bacteria, 
archaea, fungi, algae, and unicellular parasites [Saier et al. Biochim. Biophys. Acta 1999] 
operate as pentamers [Waight et al. Curr Opin Struct Biol 2013]. Each peptide complex is built 
by five identical protomers that reside in the plasma membrane [Lü et al Biol. Chem. 2013]. 
FNTs exhibit an aquaporin like architecture, referred to as molecular mimicry [Wang et al. 
Nature 2009]. Each protomer is composed of six transmembrane segments and a seventh 
pseudo helix which is formed by two half helices (figure 5.10). The inner core, which can be 
superimposed on aquaglyceroporins with r.m.s.ds of 3.3 Å, contains two constriction sites. 
These filter regions narrow the channel on the periplasmatic and on the cytoplasmatic end 
[Wang et al.  2009; Waight et al. Nat Struct Mol Biol 2010; Lü et al.  2011, 2012; Czyzewski et 
al.  2012] and are built by lipophilic amino acids being mainly leucine and phenylalanine. 
Within the central hydrophobic cavity lies a highly conserved histidine residue. It is thought of 
playing an essential role in substrate translocation since it is the only charged residue that is 
sited inside the inner channel [Waight et al. Curr Opin Struct Biol 2013]. The actual hypothesis 
is that the electrostatic potential surrounding the entrances of the channel attracts the anion. 
Once inside, there are two transport processes currently under discussion [Lü et al. Biol Chem. 
2013] (figure 5.14): the polar negatively charged ion gets transiently protonated by the 
histidine residue which passes a proton to it. Now being much more lipophilic the molecule is 
able to pass the two hydrophobic barriers. After passing the second constriction the neutral 
acid is deprotonated again. At this situation there are two possibilities for the fate of the 
proton. First, it is cycled back via a fixed water molecule, which is coordinated by a conserved 
threonine (helix-interrupting loop L2) to the histidine residue (helix-interrupting loop L5). Its 
basic side chain would be now ready to protonate another substrate molecule again. Or 
second, the anion leaves the channel together with the proton. The latter would imply that 
protons are transported together with the substrate in a 1:1 symport action. In fact there are 
arguments for both ways of transport [Lü et al. Proc Natl Acad Sci USA 2012; Lü et al. Biol 
Chem. 2013] while the prevailing pH must be considered as well. This is the case when the pH 
gradient over the membrane rises, e.g. during anaerobic energy metabolism. In this situation a 
drop of the cytosolic pH occurs due to fermentation of various weak monoacids, such as 
lactate. This is known as a physiological condition from not only Lactobacillus and Schistosoma 
spp., [Faghiri et al. PLoS One 2010] but also for Plasmodium [McKee et al. J. Exp. Med. 1946].  
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Figure 5.10 | Topology plot of PfFNT. This predicted model is based on the CdFNT3 
crystal structure [Czyzewski et al. Nature 2012] and was generated 
using TeXtopo [Beitz Bioinformatics 2000]. Amino acids of particular 
interest are highlighted. L2 and L5 denote to the intra-membrane 
loops disrupting transmembrane spans 2 and 5, respectively. One 
nonsynonymous single nucleotide polymorphism has been identified 
[Aurrecoechea et al. Nucleic Acids Res. 2009] changing His159 to Asp. 
 
 
The facilitated substrates are monovalent anions, which can be either organic or inorganic 
(figure 5.13). It seems to be a common feature of anion channels to show univalent 
polyspecificity of the transported moiety [Hille Ionic Channels of Excitable Membranes 1992; 
Yasui et al. Nature 1999; Rychkov et al. J Gen Physiol 1998]. This is contrary to what can be 
observed on for example cation channels, which display a high specificity over the channeled 
substrate [Payandeh Biochim Biophys Acta 2013; Liu et al. Nat Commun 2013; DeCoursey et al. 
J R Soc Interface 2013]. FNTs transport formate [Wang et al. Nature 2010; Lü et al. Science 
2011; Whaigt et al. Nat. Struct. Mol. Biol 2010], nitrite [Lü et al. Proc. Natl. Acad. Sci. USA 2012] 
hydrosulfite [Czyzewski et al. Nature 2012] and monocarboxylates such as lactate [Lü et al. 
Proc. Natl. Acad. Sci. USA 2012].  
We generated a model of PfFNT using the plentiful existing crystal data of the bacterial 
FNTs [Wang Nature 2009; Waight Nat. Struct. Mol. Biol 2010; Lü Proc. Natl. Acad. Sci. USA 
2012; Czyzewski Nature 2012] (figure 5.11).  
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Figure 5.11 | 3 dimensional model of PfFNT. Green = EcFocA [Wang Nature 2012; 
Waight Nat. Struct. Mol. Biol 2010]; pink = StNirC [Lü et al. Proc. Natl. 
Acad. Sci. USA 2012]; blue = CdFNT3 [Czyzewski Nature 2012]; orange 
= PfFNT. Illustrated are residues of the transport channel with the 
constriction sites as sticks and a fixed water molecule (red sphere). 
 
 
The PfFNT model aligns with sub-Ångstrom deviations at two conserved constriction sites of 
the bacterial FNTs. Furthermore it exhibits identical residues in seven of these crucial 
positions (F90, L104, T106, V196, F223, H230 and A233); the final, eighth position holds a 
phenylalanine (Phe94) instead of leucine. As already mentioned the constrictions together 
with a proton relay [Lü et al. Proc. Natl. Acad. Sci. USA 2012] consisting of a histidine (His230 
in PfFNT), a fixed water molecule, and a threonine (Thr106) are thought to define selectivity 
by transient protonation of permeating weak monoacids [Lü et al. Proc. Natl. Acad. Sci. USA 
2012]. Since the pore structures of plasmodial and bacterial FNTs resemble closely lets one 
assume similar transport properties of these peptides. The same applies for the molecular 
substrate channeling mechanism.  
 22 
 
       
 
 
Figure 1 | Identification of PfFNT as a plasmodial lact te transport r. a. Glycolytic flow in 
malaria parasites with the molecular identity of the lactate/proton symporter unknown (HT, 
hexose transporter; LDH, lactate dehydrogenase). b. Expression profile of the plasmodial hexose 
transporter (green) and candidate lactate transporters PFB0465c (purple), PFI1295c (red), and 
PfFNT (orange). Data were from plasmoDB
10,11
; transcript level is given as reads per kilobase of 
exon model per million mapped reads (RPKM)
11
. c. Identity and similarity of PfFNT (orange) to 
other plasmodial (Pb, P. berghei; Py, P. yoelii; Pc, P. chabaudi; Pk, P. knowlesi) and bacterial 
FNTs (Ec, Escherichia coli; St, Salmonella typhimurium, Cd, Clostridium difficile). d. Side view 
on the EcFocA
12,14
 (green), StNirC
15
 (pink), and CdFNT3
17
 (blue) structures plus a PfFNT model 
(orange). Depicted are residues of the transport channel with the constriction sites as sticks and a 
fixed water molecule (red sphere). e. Western blot showing plasma membrane localization of 
codon-optimised PfFNT, PFI1295c and PFB0465c in yeast. f. Growth phenotype of yeast 
without endogenous lactate transporters (jen1∆ ady2∆)19. Growth on L-lactate as the sole carbon 
source indicates lactate transport of the expressed protein. 
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Whether FNTs should be termed as channels or as transporters is still under debate. I propose 
an intermediate definition called “chansporters” [Csanády et al. EMBO Rep. 2008] due to the 
fact that their architecture resembles channels (mimicry to AQPs) but they are able to make 
use of a secondary substrate (protons) a feature exclusive for transporters (figure 5.12).  
 
 
 
Figure 5.12 | Schematic transporter and channel mechanisms. While 
transporters keep only one access gate open at a time and have an 
occluded state, channels open both sides and rapidly facilitate 
substrates over the cell membrane. In between lies the 
mechanism for “chansporters” [Csanády et al. EMBO Rep. 2008]. 
 
 
 
 
 
5   Discussion 
 
 
 
108 
5.3 PfFNT transport characteristics  
 
As already mentioned FNTs are known to transport univalent anions ranging from inorganic 
nitrite and hydrosulfide to small monocarboxylates [Lü et al Biol. Chem. 2013] (figure 5.13).  
 
 
 
Figure 5.13 | Substrate transport pattern of FNTs. Small univalent anions are 
channeled while the dicarboxylate malonate and the non-charged 
glycerol are excluded. Molecules are drawn as sticks with dots for the 
atomic radius. Generated with ChemSketch. 
 
 
Moreover FocA was shown to switch to monocarboxylate/proton symport below pH 5.7 [Lü et 
al. Science 2011]. This observation led to the following proposed actions of transport: Since 
the architecture of the conductive pore is highly conserved (figure 5.14 A) the central 
histidine is assumed to play an integral role in both states. First, it is involved in a three-step 
proton relay together with a threonine hydroxyl group, and a coordinated water molecule. 
This allows transient protonation of a monovalent anion that is able to overcome the central 
vestibule as an uncharged species (figure 5.14 B). Second, at low external pH reprotonation of 
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the conserved histidine may happen before the channeled acid is deprotonated. Dissociation 
will happen in the cytoplasm, leading to a net movement of the anion with a proton in a 1:1 
stoichiometry. This exhibits secondary active import fueled by the proton motive force (figure 
5.14 C). 
 
 
 
Figure 5.14 | Proposed transport mechanism of the FNT family. Side view on the 
conductive pore of FNTs. A) Substrates have to cross 2 barriers on 
their way through FNT, an outer constriction with a histidine and an 
inner constriction with a fixed water molecule. B) Monovalent anions 
are transiently protonated and can transcend the central vestibule as 
an uncharged species by a three-step proton relay. This involves a 
conserved histidine in the central vestibule region, a threonine 
hydroxyl group, and a coordinated water molecule. In this mode, FNT 
proteins act as bidirectional channels. C) When the external pH drops 
FNTs exhibit secondary active import fueled by the proton motive 
force. With a high external concentration of protons, reprotonation of 
the conserved histidine happens before the transported acid is 
deprotonated. In this case dissociation will happen in the cytoplasm, 
leading to a 1:1 translocation of the anion together with a proton. [Lü 
et al. Biol Chem. 2013] 
 
 
Using direct radiolabeled substrate assays the transport characteristics of the plasmodial FNT 
protein were elucidated. L-lactate was facilitated likewise to EcFocA with an initial rate of 
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transport (0.25 nm • mg-1 • min-1). The affinity to lactate (87 mM) was analog to the data 
exhibited by the homologous Salmonella typhimurium FocA (klactate 96 mM) [Lü et al. Proc. 
Natl. Acad. Sci. USA 2012]. Notably to say that the data on lactate affinity in living parasites 
underlies strong variations depending on the assay conditions ranging from 3.8 mM as 
obtained by pH-shift measurements with isolated parasites [Elliott et al. Biochem. J. 2001] to 
actually non-saturable when determined as uptake of radiolabeled lactate into permeabilised, 
infected erythrocytes [Kanaani et al. Cell. Physiol. 1991]. This remembers of affinity 
determinations of E. coli lactose permease varying 100-fold upon changing the membrane 
potential, the transmembrane proton gradient, or transiting from intact cells to vesicle 
preparations [Kaczorowski et al. Biochemistry 1979]. Interestingly, equal to FNTs, a histidine 
is protonated during transduction [Abramson et al. Science 2003]. Likewise, when the external 
pH was shifted from 6.8 to 4.8, affinity of PfFNT for lactate increased about 5-fold probably 
due to a higher level of protonation of His230. There is reliable evidence that P. falciparum 
transports lactate in a proton symport manner [Kanaani et al. Cell. Physiol. 1991; Cranmer et 
al. J. Biol. Chem. 1995; Elliott et al. Biochem. J. 2001]. According to that, lactate transport via 
PfFNT increased with acidity and was maximal at pH 3.9, i.e. the pKa of lactate (figure 5.15).  
 
 
 
Figure 5.15 | pH dependent protonation states of monocarboxylates. Towards 
pH 6 there are negligible concentrations of the lactic acid apparent, 
while at pH 3.86 the anion to acid ratio is 1:1 (pH = pKa). 
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At this pH, protonated and deprotonated moieties are equimolar. Towards more acidic 
conditions, the proportion of lactate anions decreases as did the transport rate. When the 
curve is corrected for the lactate/lactic acid ratio using the Henderson-Hasselbalch equation a 
direct correlation of pH and lactate transport is visible. This implies lactate/proton symport at 
all tested pH conditions (figure 4.25). This hypothesis can be strengthened since transport 
ceased when proton decouplers such as CCCP and DNP were applied (figure 4.26) indicating 
that the transmembrane proton gradient fuels PfFNT lactate facilitation. Additionally Dr. 
Binghua Wu was able to show that uptake of L-lactate into yeast cells coincided with 
alkalization of the weakly buffered external medium. This happened in a concentration 
dependent manner directly showing lactate/proton co-transport (figure 4.27). Besides the 
possibility of an alternate proton uptake route could be excluded by blocking Nha1. This 
peptide is the yeasts potassium / proton antiporter which was disabled by using a high 
extracellular potassium concentration (figure 4.29). Finally PfFNT was able to transport 
lactate bidirectional. This is of certain importance when the physiological situation of the 
parasite inside the RBC is considered. Still, the exact transport mechanism trough PfFNT 
remains to be elucidated. First progress was achieved by confirming proton involvement and 
requirement of a hydrogen bond interaction partner at position 106 in the channel core. For 
this T106 has been mutated to valine and serine. Giving the hydroxyl group more room 
resulted in a 50% reduced transport rate while removal of the polar hydroxyl group (T106V) 
completely ceased transport (figure 4.32). This endorsed the hypothesized triad of the proton 
relay (figure 5.14). In this situation the hydrogen bond partner of the fixed water molecule 
was exchanged by a lipophilic side chain. Therefore the water molecule was no longer kept in 
place and the proton relay was interrupted. Furthermore a first hint for the relevance of the 
central histidine was caught by using the histidine modifying agent diethylpyrocarbonate 
(DEPC). When applied there was no measurable radiolabeled lactate permeation via PfFNT 
apparent. To found this conclusion a mutation of the charged residue to phenylalanine is 
necessary. This should abolish monocarboxylate facilitation like already shown for EcFocA [Lü 
et al. Proc. Natl. Acad. Sci. USA 2012]. These experiments could contribute to ascertain the 
prevailing transport theory for FNTs. Marie Wiechert continues further research on this topic. 
Our experiments revealed two characteristics of PfFNT lactate transport. First, PfFNT 
accepts lactate in the anion form, which is protonated during transport most likely via the 
His230-water-Thr106 proton relay. Second, unlike FocA, PfFNT acts as a lactate/proton co-
transporter throughout the measured pH range. Both properties are conforming to plasmodial 
physiology. The parasite resides inside the acidic parasitophorous vacuole (figure 1.3) 
[Ginsburg Parasitol. 2002], which by protonation reduces the quantity of local vacuolar lactate 
anions. Moreover, the retention time of lactate in the parasitophorous vacuole is kept low by 
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rapid release into the host’s blood stream [Kanaani et al. Cell. Physiol. 1991; Ginsburg 
Parasitol. 2002]. Summarized, the outward gradient of lactate together with the anion 
selectivity of PfFNT drives transport in the export direction while the symport with protons 
prevents acidification of the parasite’s cytosol. 
The selectivity pattern of PfFNT is a little bit different to the one displayed by FocA [Lü 
et al. Proc. Natl. Acad. Sci. USA 2012]. Reasons for this must be found elsewhere than in the 
arrangement of the channel core since the two proteins are so close in structure in this region 
(figure 5.11). It is unlikely that this altered selectivity scheme is based on the only variation of 
the crucial pore lining amino acid composition, being phenylalanine (Phe94) instead of 
leucine. PfFNT transports besides other monovalent ion cargo molecules D-lactate 
comparable to the L enantiomer. This is consistent with the prevailing physiological state of P. 
falciparum in which as a non-enzymatic byproduct of glycolysis certain amounts of D-lactate 
(6-7% of total lactate) are produced in order to detoxify methylglyoxal [Vander et al. Mol. 
Biochem. Parasitol. 1990] (figure 5.16). The finding that dicarboxylates (malonate) and 
uncharged glycerol were not transducted fit into the affinity properties of FNTs. 
 
5   Discussion 
 
 
 
113 
 
Figure 5.16 | D-lactate formation pathway in Plasmodium falciparum. During 
glycolysis glyceraldehyde-3-phosphate and in further steps 
dihydroxyacetone phosphate are generated. This can be converted via 
non-enzymatic phosphate elimination to the cytotoxic and mutagenic 
methylglyoxal. This is further detoxified via two glyoxalases and an 
aldo-keto reductase to D-lactate [Silva et al. Int J Med Microbiol.2012]. 
GSH = glutathione; GLO1 = glyoxalase 1;  GLO2 = glyoxalase 2 
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5.4 PfFNT inhibition profile   
 
The inhibition profile found matches earlier studies in living P. falciparum parasites. There 
was shown that certain compounds, such as phloretin, furosemide, and cinnamic acid 
derivatives, inhibit plasmodial lactate transport [Cranmer et al. J. Biol. Chem. 1995; Elliott et al. 
Biochem. J. 2001] and may lead to parasite death [Kanaani et al. Antimicrob. Agents Chemother. 
1992]. Notably, the organomercurial pCMBS, that inhibits human MCTs by convalently 
binding to their essential ancillary proteins, basigin or embigin [Wilson et al. J. Biol. Chem. 
2009], does not block Plasmodium lactate transport [Cranmer et al. J. Biol. Chem. 1995]. This is 
not surprising since FNTs operate without ancillary peptides as does PfFNT, respectively. 
Confirm with the in vivo data PfFNT was not inhibited by pCMBS.  In our experiments, 
phloretin, furosemide, α-cyano-4-hydroxy-cinnamate, and α-fluorocinnamate inhibited PfFNT 
with IC50 values around 1 mM (figure 4.30). The inhibitory effect of the compounds reflects 
the data that were obtained from parasite (or infected RBC) experiments. For example α-
flourocinnamate inhibited L-lactate uptake in a range of 47% to 69% while the biflavonoid 
phloretin had an effect of about 77%, both depending on the test system and the assay 
conditions [Kanaani et al. Antimicrob. Agents Chemother. 1992; Cranmer et al. J. Biol. Chem. 
1995; Elliott et al. Biochem. J. 2001]. This thesis data fit to that with 65% inhibition effectivity 
of α-flourocinnamate and 73% for phloretin. Inhibition required a negatively charged moiety 
because the neutral cinnamamide was non-functional (figure 4.30).  
There are several things that can be learned especially from the inhibition profile of 
PFNT. First and most important the inhibitor pattern of the plasmodial FNT in our 
heterologous expression system S. cerevisiae reflects the one found in living parasites. This 
finding, together with the fact that PfFNT-GFP fusion proteins were integrated into the 
plasmodial plasma membrane (figure 4.33), implies not only a physiological but also a 
chemotherapeutic addressable function of PfFNT in malaria therapy. Second, the curves 
obtained show a competitive inhibition of the transporter. This is most likely due to the fact 
that all chemicals (except phloretin and furosemide) have the functional group α-hydroxy-
carboxylic acid as structural element mimicking lactate. The theory is that the bulkier 
aromatic elements of these molecules prohibit a transduction by getting stuck in the pore 
entrance of PfFNT. Even though these compounds offer no alternative for medical treatment 
of clinical malaria in humans since their affinity to the permease is too low, one could think of 
an alternate use. They could serve as a lead structure for an inhibitor which would have been 
chemically optimized to perfectly fit to the pore and with this have a much higher affinity than 
lactate. Prerequisite for this is a high resolution crystal structure of PfFNT. Experiments 
towards this goal are currently performed in this group. Third, FNT inhibitors could have the 
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potential to act as a novel class of antibiotics. We were able to inhibit EcFocA with α-
flourocinnamate (figure 4.31). Although there won’t be applicability for medical treatment of 
infections caused by E. coli (normal growth of a FocA knock out strain) [Tran et al. Appl 
Microbiol Biotechnol 2014] it might be for Salmonella. NirC is believed to be an important 
virulence factor and blockage of it could proof as a possible new drug target [Das et al. 
Microbiology 2009]. 
 
 
5.5 Outlook 
 
In the future when the crystal structure of PfFNT will be revealed in silico designed and 
chemically synthetized inhibitors may ascertain whether the transporter is a valuable drug 
target in the fight against malaria or not. Nevertheless first inhibitor experiments targeting 
anion transporters revealed the potential to kill parasites in vitro. The basic requirements as a 
drug target are prevailing though. There is no sequence for a structural related protein 
apparent in the human genome which dramatically reduces the possibility of drug related side 
effects. 
6   Literature 
 
 
 
116 
6 Literature 
 
Aikawa M. The fine structure of the erythrocytic stages of three avian malarial parasites, 
Plasmodium fallax, P. lophurae, and P. cathemerium. Am J Trop Med Hyg. 1966; 15(4):449-71. 
Abramson J, Smirnova I, Kasho V, Verner G, Kaback HR, Iwata S. Structure and mechanism of 
the lactose permease of Escherichia coli. Science. 2003; 301(5633):610-5. 
Aurrecoechea C, Brestelli J, Brunk BP, Dommer J, Fischer S, Gajria B, Gao X, Gingle A, Grant G, 
Harb OS, Heiges M, Innamorato F, Iodice J, Kissinger JC, Kraemer E, Li W, Miller JA, Nayak V, 
Pennington C, Pinney DF, Roos DS, Ross C, Stoeckert CJ Jr, Treatman C, Wang H. PlasmoDB: a 
functional genomic database for malaria parasites. Nucleic Acids Res. 2009; 37(Database 
issue):D539-43. 
Bártfai R, Hoeijmakers WA, Salcedo-Amaya AM, Smits AH, Janssen-Megens E, Kaan A, Treeck 
M, Gilberger TW, Françoijs KJ, Stunnenberg HG. H2A.Z demarcates intergenic regions of the 
plasmodium falciparum epigenome that are dynamically marked by H3K9ac and H3K4me3. 
PLoS Pathog. 2010; 6(12):e1001223. 
Baudin A, Ozier-Kalogeropoulos O, Denouel A, Lacroute F, Cullin C. A simple and efficient 
method for direct gene deletion in Saccharomyces cerevisiae. Nucleic Acids Res. 1993; 
21(14):3329-30. 
Beitz E. T(E)Xtopo: shaded membrane protein topology plots in LAT(E)X2epsilon. 
Bioinformatics. 2000; 16(11):1050-1. 
Beitz E. TEXshade: shading and labeling of multiple sequence alignments using LATEX2 
epsilon. Bioinformatics. 2000; 16(2):135-9. 
Bienert GP, Desguin B, Chaumont F, Hols P. Channel-mediated lactic acid transport: a novel 
function for aquaglyceroporins in bacteria. Biochem J. 2013; 454(3):559-70. 
Bröer S, Schneider HP, Bröer A, Rahman B, Hamprecht B, Deitmer JW. Characterization of the 
monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic 
pH. Biochem J. 1998; 333 ( Pt 1):167-74. 
6   Literature 
 
 
 
117 
Brooks JT, Elvidge GP, Glenny L, Gleadle JM, Liu C, Ragoussis J, Smith TG, Talbot NP, 
Winchester L, Maxwell PH, Robbins PA. Variations within oxygen-regulated gene expression 
in humans. J Appl Physiol (1985). 2009; 106(1):212-20. 
Choi WG, Roberts DM. Arabidopsis NIP2;1, a major intrinsic protein transporter of lactic acid 
induced by anoxic stress. J Biol Chem. 2007; 282(33):24209-18. 
Clegg S, Yu F, Griffiths L, Cole JA. The roles of the polytopic membrane proteins NarK, NarU 
and NirC in Escherichia coli K-12: two nitrate and three nitrite transporters. Mol Microbiol. 
2002; 44(1):143-55. 
Cori CF, Cori GT. Carbohydrate metabolism. Annu Rev Biochem. 1946; 15:193-218  
Crabb BS, Cooke BM, Reeder JC, Waller RF, Caruana SR, Davern KM, Wickham ME, Brown GV, 
Coppel RL, Cowman AF. Targeted gene disruption shows that knobs enable malaria-infected 
red cells to cytoadhere under physiological shear stress. Cell. 1997; 89(2):287-96 
Cranmer SL, Conant AR, Gutteridge WE, Halestrap AP. Characterization of the enhanced 
transport of L- and D-lactate into human red blood cells infected with Plasmodium falciparum 
suggests the presence of a novel saturable lactate proton cotransporter. J Biol Chem. 1995; 
270(25):15045-52. 
Crosnier C, Bustamante LY, Bartholdson SJ, Bei AK, Theron M, Uchikawa M, Mboup S, Ndir O, 
Kwiatkowski DP, Duraisingh MT, Rayner JC, Wright GJ. Basigin is a receptor essential for 
erythrocyte invasion by Plasmodium falciparum. Nature. 2011; 480(7378):534-7. 
Csanády L, Mindell JA. The twain shall meet: channels, transporters and things between. 
Meeting on Membrane Transport in Flux: the Ambiguous Interface Between Channels and 
Pumps. EMBO Rep. 2008; 9(10):960-5. 
Czyzewski BK, Wang DN. Identification and characterization of a bacterial hydrosulphide ion 
channel. Nature. 2012; 483(7390):494-7. 
Das P, Lahiri A, Lahiri A, Chakravortty D. Novel role of the nitrite transporter NirC in 
Salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in 
activated macrophages. Microbiology. 2009; 155(Pt 8):2476-89. 
6   Literature 
 
 
 
118 
de Kok S, Nijkamp JF, Oud B, Roque FC, de Ridder D, Daran JM, Pronk JT, van Maris AJ. 
Laboratory evolution of new lactate transporter genes in a jen1Δ mutant of Saccharomyces 
cerevisiae and their identification as ADY2 alleles by whole-genome resequencing and 
transcriptome analysis. FEMS Yeast Res. 2012. 
DeCoursey TE, Hosler J. Philosophy of voltage-gated proton channels. J R Soc Interface. 2013; 
11(92):20130799. 
Desai SA, Krogstad DJ, McCleskey EW. A nutrient-permeable channel on the intraerythrocytic 
malaria parasite. Nature. 1993; 362(6421):643-6. 
Dimmer KS, Friedrich B, Lang F, Deitmer JW, Bröer S. The low-affinity monocarboxylate 
transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J. 2000; 
350 Pt 1:219-27. 
Elliott JL, Saliba KJ, Kirk K. Transport of lactate and pyruvate in the intraerythrocytic malaria 
parasite, Plasmodium falciparum. Biochem J. 2001; 355(Pt 3):733-9. 
Faghiri Z, Camargo SM, Huggel K, Forster IC, Ndegwa D, Verrey F, Skelly PJ. The tegument of 
the human parasitic worm Schistosoma mansoni as an excretory organ: the surface aquaporin 
SmAQP is a lactate transporter. PLoS One. 2010; 5(5):e10451. 
Francia ME, Striepen B. Cell division in apicomplexan parasites. Nat Rev Microbiol. 2014; 
12(2):125-36. 
Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, 
Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, 
Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather 
MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, 
Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, 
Davis RW, Fraser CM, Barrell B. Genome sequence of the human malaria parasite Plasmodium 
falciparum. Nature. 2002; 419(6906):498-511. 
Ginsburg H. Abundant proton pumping in Plasmodium falciparum, but why? Trends Parasitol. 
2002; 18(11):483-6. 
6   Literature 
 
 
 
119 
Halestrap AP. The monocarboxylate transporter family--Structure and functional 
characterization. IUBMB Life. 2012; 64(1):1-9. 
Halestrap AP. The SLC16 gene family - structure, role and regulation in health and disease. Mol 
Aspects Med. 2013; 34(2-3):337-49. 
Heiber A, Kruse F, Pick C, Grüring C, Flemming S, Oberli A, Schoeler H, Retzlaff S, Mesén-
Ramírez P, Hiss JA, Kadekoppala M, Hecht L, Holder AA, Gilberger TW, Spielmann T. 
Identification of new PNEPs indicates a substantial non-PEXEL exportome and underpins 
common features in Plasmodium falciparum protein export. PLoS Pathog. 2013; 
9(8):e1003546. 
Hille B. Ionic channels in excitable membranes. Current problems and biophysical approaches. 
Biophys J. 1978; 22(2):283-94 
Jia W, Tovell N, Clegg S, Trimmer M, Cole J. A single channel for nitrate uptake, nitrite export 
and nitrite uptake by Escherichia coli NarU and a role for NirC in nitrite export and uptake. 
Biochem J. 2009; 417(1):297-304. 
Kabil O, Banerjee R. Redox biochemistry of hydrogen sulfide. J Biol Chem. 2010; 
285(29):21903-7. 
Kaczorowski GJ, Kaback HR. Mechanism of lactose translocation in membrane vesicles from 
Escherichia coli. 1. Effect of pH on efflux, exchange, and counterflow. Biochemistry. 1979; 
18(17):3691-7. 
Kanaani J, Ginsburg H. Effects of cinnamic acid derivatives on in vitro growth of Plasmodium 
falciparum and on the permeability of the membrane of malaria-infected erythrocytes. 
Antimicrob Agents Chemother. 1992; 36(5):1102-8. 
Kanaani J, Ginsburg H. Transport of lactate in Plasmodium falciparum-infected human 
erythrocytes. J Cell Physiol. 1991; 149(3):469-76. 
Kobayashi M, Otsuka Y, Itagaki S, Hirano T, Iseki K. Inhibitory effects of statins on human 
monocarboxylate transporter 4. Int J Pharm. 2006; 317(1):19-25. 
6   Literature 
 
 
 
120 
Krungkrai J, Burat D, Kudan S, Krungkrai S, Prapunwattana P. Mitochondrial oxygen 
consumption in asexual and sexual blood stages of the human malarial parasite, Plasmodium 
falciparum. Southeast Asian J Trop Med Public Health. 1999; 30(4):636-42. 
Kumar S, Bandyopadhyay U. Free heme toxicity and its detoxification systems in human. 
Toxicol Lett. 2005; 157(3):175-88.  
Liu J, Istvan ES, Gluzman IY, Gross J, Goldberg DE. Plasmodium falciparum ensures its amino 
acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. 
Proc Natl Acad Sci U S A. 2006; 103(23):8840-5.  
Liu S, Lockless SW. Equilibrium selectivity alone does not create K+-selective ion conduction 
in K+ channels. Nat Commun. 2013; 4:2746. 
Lü W, Du J, Schwarzer NJ, Wacker T, Andrade SL, Einsle O. The formate/nitrite transporter 
family of anion channels. Biol Chem. 2013; 394(6):715-27. 
Lü W, Du J, Wacker T, Gerbig-Smentek E, Andrade SL, Einsle O. pH-dependent gating in a FocA 
formate channel. Science. 2011; 332(6027):352-4. 
Makuc J, Paiva S, Schauen M, Krämer R, André B, Casal M, Leão C, Boles E. The putative 
monocarboxylate permeases of the yeast Saccharomyces cerevisiae do not transport 
monocarboxylic acids across the plasma membrane. Yeast. 2001; 18(12):1131-43. 
Manning Fox JE, Meredith D, Halestrap AP. Characterisation of human monocarboxylate 
transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J Physiol. 2000; 
529 Pt 2:285-93. 
Manoharan C, Wilson MC, Sessions RB, Halestrap AP. The role of charged residues in the 
transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in 
determining plasma membrane expression and catalytic activity. Mol Membr Biol. 2006; 
23(6):486-98 
Markus MB. The hypnozoite concept, with particular reference to malaria. Parasitol Res. 2011; 
108(1):247-52. 
6   Literature 
 
 
 
121 
Martínez-Muñoz GA, Kane P. Vacuolar and plasma membrane proton pumps collaborate to 
achieve cytosolic pH homeostasis in yeast. J Biol Chem. 2008; 283(29):20309-19. 
McKee RW, Ormsbee RA, Anfinsen CB, Geiman QM, Ball EG. Studies on malarial parasites : VI. 
The chemistry and metabolism of normal and parasitized (p. Knowlesi) monkey blood. J Exp 
Med. 1946; 84(6):569-82. 
McLaughlin SG, Dilger JP. Transport of protons across membranes by weak acids. Physiol Rev. 
1980; 60(3):825-63. 
Miller LH, Roberts T, Shahabuddin M, McCutchan TF. Analysis of sequence diversity in the 
Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol Biochem Parasitol. 1993; 
59(1):1-14. 
Morelli A, Benatti U, Gaetani GF, De Flora A. Biochemical mechanisms of glucose-6-phosphate 
dehydrogenase deficiency. Proc Natl Acad Sci U S A. 1978; 75(4):1979-83. 
Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather 
MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, 
Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, 
Davis RW, Fraser CM, Barrell B. Genome sequence of the human malaria parasite Plasmodium 
falciparum. Nature. 2002; 419(6906):498-511. 
Olszewski KL, Llinás M. Central carbon metabolism of Plasmodium parasites. Mol Biochem 
Parasitol. 2011; 175(2):95-103. 
Otto M, Rapoport TA, Heinrich R. An extended model of the glycolysis in erythrocytes. Acta 
Biol Med Ger. 1977; 36(3-4):461-8. 
Paiva S, Devaux F, Barbosa S, Jacq C, Casal M. Ady2p is essential for the acetate permease 
activity in the yeast Saccharomyces cerevisiae. Yeast. 2004; 21(3):201-10. 
Payandeh J, Pfoh R, Pai EF. The structure and regulation of magnesium selective ion channels. 
Biochim Biophys Acta. 2013; 1828(11):2778-92. 
6   Literature 
 
 
 
122 
Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian 
plasma membranes. Am J Physiol. 1993; 264(4 Pt 1):C761-82. 
Rambow J, Wu B, Rönfeldt D, Beitz E. Aquaporins with anion/monocarboxylate permeability: 
mechanisms, relevance for pathogen-host interactions. Front Pharmacol. 2014; 5:199. 
Roigas H, Dietze F, Rapoport S, Sauer G. On the effect of glycolytic intermediary products on 
the 2,3-PGase activity of red blood cells. Folia Haematol Int Mag Klin Morphol Blutforsch. 1965; 
83(4):383-8. 
Roth E Jr. Plasmodium falciparum carbohydrate metabolism: a connection between host cell 
and parasite. Blood Cells. 1990; 16(2-3):453-60. 
Rudzinska MA. The fine structure of malaria parasites. Int Rev Cytol. 1969; 25:161-99. 
Rychkov GY, Pusch M, Roberts ML, Jentsch TJ, Bretag AH. Permeation and block of the skeletal 
muscle chloride channel, ClC-1, by foreign anions. J Gen Physiol. 1998; 111(5):653-65. 
Saier MH Jr, Eng BH, Fard S, Garg J, Haggerty DA, Hutchinson WJ, Jack DL, Lai EC, Liu HJ, 
Nusinew DP, Omar AM, Pao SS, Paulsen IT, Quan JA, Sliwinski M, Tseng TT, Wachi S, Young GB. 
Phylogenetic characterization of novel transport protein families revealed by genome 
analyses. Biochim Biophys Acta. 1999; 1422(1):1-56. 
Saliba KJ, Horner HA, Kirk K. Transport and metabolism of the essential vitamin pantothenic 
acid in human erythrocytes infected with the malaria parasite Plasmodium falciparum. J Biol 
Chem. 1998; 273(17):10190-5. 
Sanchez MA. Molecular identification and characterization of an essential pyruvate 
transporter from Trypanosoma brucei. J Biol Chem. 2013; 288(20):14428-37. 
Sawers G. The hydrogenases and formate dehydrogenases of Escherichia coli. Antonie Van 
Leeuwenhoek. 1994; 66(1-3):57-88. 
Sawers RG. Differential turnover of the multiple processed transcripts of the Escherichia coli 
focA-pflB operon. Microbiology. 2006; 152(Pt 8):2197-205. 
6   Literature 
 
 
 
123 
Scheibel LW, Ashton SH, Trager W. Plasmodium falciparum: microaerophilic requirements in 
human red blood cells. Exp Parasitol. 1979; 47(3):410-8. 
Smith RC, Vega-Rodríguez J, Jacobs-Lorena M. The Plasmodium bottleneck: malaria parasite 
losses in the mosquito vector. Mem Inst Oswaldo Cruz. 2014; 109(5):644-61. 
Soares-Silva I, Paiva S, Diallinas G, Casal M. The conserved sequence 
NXX[S/T]HX[S/T]QDXXXT of the lactate/pyruvate:H(+) symporter subfamily defines the 
function of the substrate translocation pathway. Mol Membr Biol. 2007; 24(5-6):464-74. 
Sousa Silva M, Ferreira AE, Gomes R, Tomás AM, Ponces Freire A, Cordeiro C. The glyoxalase 
pathway in protozoan parasites. Int J Med Microbiol. 2012; 302(4-5):225-9. 
Stephenson M, Stickland LH. Hydrogenlyases: Bacterial enzymes liberating molecular 
hydrogen. Biochem J. 1932; 26(3):712-24. 
Stokes JL. Fermentation of glucose by suspensions of Escherichia coli. J Bacteriol. 1949; 
57(2):147-58.  
Sui H, Han BG, Lee JK, Walian P, Jap BK. Structural basis of water-specific transport through 
the AQP1 water channel. Nature. 2001; 414(6866):872-8. 
Suppmann B, Sawers G. Isolation and characterization of hypophosphite--resistant mutants of 
Escherichia coli: identification of the FocA protein, encoded by the pfl operon, as a putative 
formate transporter. Mol Microbiol. 1994; 11(5):965-82. 
Torrentino-Madamet M, Desplans J, Travaillé C, James Y, Parzy D. Microaerophilic respiratory 
metabolism of Plasmodium falciparum mitochondrion as a drug target. Curr Mol Med. 2010; 
10(1):29-46. 
Trager W, Jensen JB. Human malaria parasites in continuous culture. Science. 1976; 
193(4254):673-5. 
Tran KT, Maeda T, Wood TK. Metabolic engineering of Escherichia coli to enhance hydrogen 
production from glycerol. Appl Microbiol Biotechnol. 2014; 98(10):4757-70. 
6   Literature 
 
 
 
124 
Tsukaguchi H, Shayakul C, Berger UV, Mackenzie B, Devidas S, Guggino WB, van Hoek AN, 
Hediger MA. Molecular characterization of a broad selectivity neutral solute channel. J Biol 
Chem. 1998; 273(38):24737-43. 
Vander Jagt DL, Hunsaker LA, Campos NM, Baack BR. D-lactate production in erythrocytes 
infected with Plasmodium falciparum. Mol Biochem Parasitol. 1990; 42(2):277-84. 
van Dooren GG, Stimmler LM, McFadden GI. Metabolic maps and functions of the Plasmodium 
mitochondrion. FEMS Microbiol Rev. 2006; 30(4):596-630. 
Waight AB, Czyzewski BK, Wang DN. Ion selectivity and gating mechanisms of FNT channels. 
Curr Opin Struct Biol. 2013; 23(4):499-506. 
Waight AB, Love J, Wang DN. Structure and mechanism of a pentameric formate channel. Nat 
Struct Mol Biol. 2010; 17(1):31-7. 
Waller RF, McFadden GI. The apicoplast: a review of the derived plastid of apicomplexan 
parasites. Curr Issues Mol Biol. 2005; 7(1):57-79. 
Wang Y, Huang Y, Wang J, Cheng C, Huang W, Lu P, Xu YN, Wang P, Yan N, Shi Y. Structure of 
the formate transporter FocA reveals a pentameric aquaporin-like channel. Nature. 2009; 
462(7272):467-72. 
Wassmer SC, Combes V, Grau GE. Pathophysiology of cerebral malaria: role of host cells in the 
modulation of cytoadhesion. Ann N Y Acad Sci. 2003; 992:30-8. 
Wilson MC, Meredith D, Bunnun C, Sessions RB, Halestrap AP. Studies on the DIDS-binding site 
of monocarboxylate transporter 1 suggest a homology model of the open conformation and a 
plausible translocation cycle. J Biol Chem. 2009; 284(30):20011-21. 
Worthington DJ, Rosemeyer MA. Glutathione reductase from human erythrocytes. Catalytic 
properties and aggregation. Eur J Biochem. 1976; 67(1):231-8. 
Yasui M, Hazama A, Kwon TH, Nielsen S, Guggino WB, Agre P. Rapid gating and anion 
permeability of an intracellular aquaporin. Nature. 1999; 402(6758):184-7. 
Publications 
 
 
 
125 
Publications 
 
Rambow J, Wu B, Rönfeldt D, Beitz E. Aquaporins with anion/monocarboxylate permeability: 
mechanisms, relevance for pathogen-host interactions. Front Pharmacol. 2014; doi: 10.3389 
 
Rambow J, Wu B, Bock S, Holm-Bertelsen J, Wiechert M, Blancke-Soares A, Spielmann T, Beitz 
E. Identity of a Plasmodium lactate/H+ symporter structurally unrelated to human 
transporters. Nat. Commun. 2015; currently under review 
Acknowledgements 
 
 
 
126 
Acknowledgements 
 
It is well-known that state of the art science is a multitasking challenge where well-rehearsed 
teams achieve goals that one alone could never accomplish. This team does not end at the 
doorstep of the workplace. Without all of you - your support, your care and your aid this 
thesis would have never been written. I am deeply grateful for this, thank you. 
First of all I would like to thank my advisor Eric for giving me the opportunity to do 
what I love – gain knowledge in fields no one has ever explored before. His door is always 
open for asking questions and discussing problems and I never left his office without new 
ideas or a better understanding of my results. 
Furthermore I would like to thank my colleagues for the good working atmosphere. We 
have a great team where everybody offers a helping hand when needed. My special thanks go 
to Ellen and Sinja, we had a great time together in the office. 
Also I would like to thank Dirk Böhme. His ideas and inventions were not only helpful 
without him there would be no radioactive assay at all. And I had a lot of good chats with him. 
Moreover I owe thanks to my colleagues who took care of the students in the second 
semester with me. Each semester, after the first days when we were more or less certain that 
none of the students would cause a major explosion, we enjoyed the time together. I will 
certainly miss the days when we got handed over the record cards for each semester. 
In addition I would like to thank my friends, those which I had before I started my thesis 
and those which I met during doing it. I will always keep good memory of going out for lunch 
at the mensa with a coffee afterwards or having a party. 
Last but not least I thank my family, my parents and my little brother. You not only 
supported me in every way, you are my backbone and my home. I love you with all my heart. 
Curriculum Vitae 
 
 
 
127 
Curriculum Vitae  
 
Janis Rambow 
geboren am:  13.03.1984 
geboren in: Kiel  
Nationalität  Deutsch 
 
 
Schule und Studium 
 
2004  Abitur, Hebbelschule Kiel 
2005 Zivildienst, mobile Frühförderung Kiel 
2009  zweites Staatsexamen Pharmazie, Universität zu Kiel 
2010  Apotheker im praktischen Jahr, Planton GmbH Kiel 
2010  Apotheker im praktischen Jahr, Esmarch Apotheke Kiel 
2011 Approbation als Apotheker 
 
 
Promotion 
 
seit 2011 Wissenschaftlicher Mitarbeiter am pharmazeutischen Institut unter Leitung  
  von Prof. Dr. E. Beitz,  
Abteilung pharmazeutische und medizinische Chemie, 
Christian-Albrechts-Universität zu Kiel  
Eidesstattliche Erklärung 
 
 
 
128 
Eidesstattliche Erklärung 
 
Hiermit versichere ich, dass ich die vorliegende Abhandlung, abgesehen von der Beratung 
durch den Betreuer, selbstständig verfasst und keine anderen als die angegebenen Quellen 
und Hilfsmittel benutzt habe, dass alle Stellen der Arbeit, die wörtlich oder sinngemäß aus 
anderen Quellen übernommen wurden, als solche kenntlich gemacht sind. Die Arbeit wurde 
bisher in gleicher oder ähnlicher Form noch keiner Prüfungsbehörde vorgelegt.  
Die Arbeit ist unter Einhaltung der Regeln zur guten wissenschaftlichen Praxis der 
Deutschen Forschungsgemeinschaft entstanden. 
 
 
 
 
 
Kiel, den 06. Januar 2015 
Janis Rambow 
